SPTN 10-Q Quarterly Report Oct. 7, 2023 | Alphaminr

SPTN 10-Q Quarter ended Oct. 7, 2023

SPARTANNASH CO
10-Ks and 10-Qs
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
10-Q
false --12-31 0000877422 Q3 0000877422 sptn:CenterStoreMember sptn:WholesaleMember 2023-01-01 2023-10-07 0000877422 sptn:CenterStoreMember sptn:RetailSegmentMember 2022-07-17 2022-10-08 0000877422 sptn:IndividualsCustomerMember sptn:RetailSegmentMember 2022-01-02 2022-10-08 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2022-01-02 2022-04-23 0000877422 us-gaap:PensionPlansDefinedBenefitMember sptn:SpartanNashMedicalPlanMember 2022-01-02 2022-10-08 0000877422 sptn:WholesaleMember us-gaap:IntersegmentEliminationMember 2022-01-02 2022-10-08 0000877422 sptn:WholesaleMember sptn:MilitaryMember 2022-07-17 2022-10-08 0000877422 us-gaap:CommonStockMember 2022-07-16 0000877422 sptn:SpartanNashMedicalPlanMember 2022-07-01 2022-07-01 0000877422 sptn:LongTermNotesReceivableMember 2023-10-07 0000877422 us-gaap:RetainedEarningsMember 2022-12-31 0000877422 2023-04-22 0000877422 sptn:MilitaryMember 2023-07-16 2023-10-07 0000877422 srt:FuelMember 2022-01-02 2022-10-08 0000877422 us-gaap:EmployeeSeveranceMember 2023-01-01 2023-10-07 0000877422 us-gaap:RetainedEarningsMember 2023-01-01 2023-04-22 0000877422 us-gaap:PerformanceSharesMember 2023-10-07 0000877422 sptn:OtherProductMember 2023-07-16 2023-10-07 0000877422 sptn:IndependentRetailersMember 2023-07-16 2023-10-07 0000877422 sptn:CurrentAccountsAndNotesReceivableMember 2023-01-01 2023-10-07 0000877422 sptn:CenterStoreMember 2023-01-01 2023-10-07 0000877422 2022-10-08 0000877422 sptn:OtherCustomersMember 2022-07-17 2022-10-08 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2022-01-01 0000877422 sptn:LongTermNotesReceivableMember 2023-01-01 2023-10-07 0000877422 sptn:WholesaleMember sptn:OtherCustomersMember 2022-01-02 2022-10-08 0000877422 us-gaap:RetainedEarningsMember 2023-04-22 0000877422 sptn:CurrentAccountsAndNotesReceivableMember 2022-01-02 2022-10-08 0000877422 sptn:WholesaleMember sptn:OtherProductMember 2023-07-16 2023-10-07 0000877422 us-gaap:PensionPlansDefinedBenefitMember sptn:SpartanNashMedicalPlanMember 2022-07-17 2022-10-08 0000877422 us-gaap:OperatingSegmentsMember sptn:WholesaleMember 2023-01-01 2023-10-07 0000877422 us-gaap:RestrictedStockMember 2023-07-16 2023-10-07 0000877422 us-gaap:OperatingSegmentsMember sptn:WholesaleMember 2022-01-02 2022-10-08 0000877422 sptn:NonFoodMember 2023-07-16 2023-10-07 0000877422 us-gaap:RetainedEarningsMember 2022-07-16 0000877422 sptn:NonFoodMember 2022-01-02 2022-10-08 0000877422 sptn:IndependentRetailersMember sptn:WholesaleMember 2022-07-17 2022-10-08 0000877422 us-gaap:IntersegmentEliminationMember 2022-01-02 2022-10-08 0000877422 sptn:CenterStoreMember sptn:WholesaleMember 2022-01-02 2022-10-08 0000877422 2022-12-31 0000877422 sptn:WholesaleMember sptn:FreshMember 2022-01-02 2022-10-08 0000877422 sptn:IndividualsCustomerMember 2022-01-02 2022-10-08 0000877422 sptn:WholesaleMember sptn:NationalAccountsMember 2022-07-17 2022-10-08 0000877422 2023-04-23 2023-07-15 0000877422 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-10-08 0000877422 sptn:RetailSegmentMember 2023-01-01 2023-10-07 0000877422 sptn:WholesaleMember us-gaap:IntersegmentEliminationMember 2023-01-01 2023-10-07 0000877422 sptn:NonFoodMember 2023-01-01 2023-10-07 0000877422 sptn:NonFoodMember sptn:WholesaleMember 2022-01-02 2022-10-08 0000877422 sptn:WarrantsTwoMember sptn:CommercialAgreementMember sptn:NVInvestmentHoldingsMember 2020-10-07 0000877422 sptn:NonFoodMember sptn:WholesaleMember 2023-01-01 2023-10-07 0000877422 us-gaap:CommonStockMember 2023-10-07 0000877422 sptn:OtherCustomersMember sptn:RetailSegmentMember 2022-01-02 2022-10-08 0000877422 us-gaap:WarrantMember 2023-07-16 2023-10-07 0000877422 us-gaap:WarrantMember 2023-01-01 2023-10-07 0000877422 sptn:WholesaleMember sptn:NationalAccountsMember 2023-01-01 2023-10-07 0000877422 us-gaap:CommonStockMember 2022-10-08 0000877422 sptn:OtherProductMember 2022-07-17 2022-10-08 0000877422 sptn:WarrantsOneMember sptn:CommercialAgreementMember sptn:NVInvestmentHoldingsMember 2020-10-07 2020-10-07 0000877422 sptn:IndependentRetailersMember sptn:WholesaleMember 2022-01-02 2022-10-08 0000877422 sptn:WholesaleMember 2023-07-16 2023-10-07 0000877422 sptn:RetailSegmentMember us-gaap:IntersegmentEliminationMember 2023-07-16 2023-10-07 0000877422 sptn:RetailSegmentMember 2023-10-07 0000877422 sptn:RetailSegmentMember 2023-07-16 2023-10-07 0000877422 srt:FuelMember sptn:RetailSegmentMember 2023-01-01 2023-10-07 0000877422 sptn:OtherCustomersMember sptn:RetailSegmentMember 2022-07-17 2022-10-08 0000877422 us-gaap:CommonStockMember 2022-04-23 0000877422 sptn:MilitaryMember 2022-07-17 2022-10-08 0000877422 us-gaap:BusinessRestructuringReservesMember 2023-01-01 2023-10-07 0000877422 2023-01-01 2023-10-07 0000877422 us-gaap:RetainedEarningsMember 2023-07-15 0000877422 sptn:WholesaleMember sptn:OtherProductMember 2022-07-17 2022-10-08 0000877422 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-10-07 0000877422 sptn:LongTermNotesReceivableMember 2022-01-01 0000877422 sptn:WholesaleMember sptn:OtherCustomersMember 2023-07-16 2023-10-07 0000877422 us-gaap:OperatingSegmentsMember sptn:RetailSegmentMember 2022-01-02 2022-10-08 0000877422 us-gaap:RetainedEarningsMember 2022-10-08 0000877422 sptn:OtherProductMember 2022-01-02 2022-10-08 0000877422 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-01-01 2023-10-07 0000877422 sptn:IndependentRetailersMember sptn:WholesaleMember 2023-07-16 2023-10-07 0000877422 sptn:RetailSegmentMember sptn:OtherProductMember 2023-07-16 2023-10-07 0000877422 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-10-07 0000877422 sptn:LeaseAndAncillaryCostsMember 2023-10-07 0000877422 us-gaap:CommonStockMember 2022-01-02 2022-04-23 0000877422 sptn:FreshMember 2023-01-01 2023-10-07 0000877422 sptn:CenterStoreMember 2022-01-02 2022-10-08 0000877422 sptn:NonFoodMember sptn:RetailSegmentMember 2022-07-17 2022-10-08 0000877422 us-gaap:PensionPlansDefinedBenefitMember sptn:SpartanNashMedicalPlanMember 2023-07-16 2023-10-07 0000877422 us-gaap:IntersegmentEliminationMember 2023-07-16 2023-10-07 0000877422 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-01-02 2022-10-08 0000877422 us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2023-07-16 2023-10-07 0000877422 sptn:IndividualsCustomerMember 2023-07-16 2023-10-07 0000877422 us-gaap:IntersegmentEliminationMember 2022-07-17 2022-10-08 0000877422 us-gaap:BusinessRestructuringReservesMember 2022-07-17 2022-10-08 0000877422 sptn:RetailSegmentMember 2022-01-02 2022-10-08 0000877422 us-gaap:WarrantMember 2022-01-02 2022-10-08 0000877422 sptn:RetailSegmentMember sptn:FreshMember 2023-07-16 2023-10-07 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2023-07-16 2023-10-07 0000877422 us-gaap:RetainedEarningsMember 2022-01-01 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2023-04-22 0000877422 sptn:OtherCustomersMember 2022-01-02 2022-10-08 0000877422 sptn:CenterStoreMember sptn:WholesaleMember 2023-07-16 2023-10-07 0000877422 sptn:NonFoodMember sptn:RetailSegmentMember 2022-01-02 2022-10-08 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2022-12-31 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2023-07-15 0000877422 sptn:NonFoodMember sptn:WholesaleMember 2023-07-16 2023-10-07 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2022-10-08 0000877422 sptn:RetailSegmentMember sptn:OtherProductMember 2022-01-02 2022-10-08 0000877422 sptn:NationalAccountsMember 2022-01-02 2022-10-08 0000877422 2022-01-02 2022-04-23 0000877422 sptn:CurrentAccountsAndNotesReceivableMember 2022-01-01 0000877422 sptn:NationalAccountsMember 2023-07-16 2023-10-07 0000877422 sptn:WholesaleMember sptn:MilitaryMember 2023-07-16 2023-10-07 0000877422 sptn:MilitaryMember 2023-01-01 2023-10-07 0000877422 sptn:NonFoodMember sptn:RetailSegmentMember 2023-07-16 2023-10-07 0000877422 sptn:RetailSegmentMember us-gaap:IntersegmentEliminationMember 2023-01-01 2023-10-07 0000877422 sptn:OtherProductMember sptn:RetailSegmentMember 2023-01-01 2023-10-07 0000877422 2022-01-01 0000877422 sptn:CenterStoreMember 2022-07-17 2022-10-08 0000877422 us-gaap:RetainedEarningsMember 2022-04-24 2022-07-16 0000877422 sptn:RetailSegmentMember us-gaap:IntersegmentEliminationMember 2022-07-17 2022-10-08 0000877422 sptn:NonFoodMember sptn:RetailSegmentMember 2023-01-01 2023-10-07 0000877422 us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2023-01-01 2023-10-07 0000877422 us-gaap:InterestRateSwapMember 2023-10-07 0000877422 us-gaap:RestrictedStockMember 2022-07-17 2022-10-08 0000877422 us-gaap:RetainedEarningsMember 2022-07-17 2022-10-08 0000877422 srt:FuelMember sptn:RetailSegmentMember 2022-07-17 2022-10-08 0000877422 sptn:NationalAccountsMember 2022-07-17 2022-10-08 0000877422 sptn:NVInvestmentHoldingsMember sptn:CommercialAgreementMember 2020-10-07 0000877422 sptn:IndependentRetailersMember 2023-01-01 2023-10-07 0000877422 sptn:LeaseAndAncillaryCostsMember 2022-12-31 0000877422 us-gaap:RestrictedStockMember 2023-01-01 2023-10-07 0000877422 sptn:OtherCustomersMember sptn:WholesaleMember 2023-01-01 2023-10-07 0000877422 us-gaap:OperatingSegmentsMember sptn:WholesaleMember 2022-07-17 2022-10-08 0000877422 sptn:FreshMember 2023-07-16 2023-10-07 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2022-07-17 2022-10-08 0000877422 2022-07-17 2022-10-08 0000877422 us-gaap:CommonStockMember 2023-04-23 2023-07-15 0000877422 sptn:WholesaleMember sptn:MilitaryMember 2023-01-01 2023-10-07 0000877422 srt:FuelMember 2023-01-01 2023-10-07 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2022-04-24 2022-07-16 0000877422 sptn:IndependentRetailersMember sptn:WholesaleMember 2023-01-01 2023-10-07 0000877422 sptn:FreshMember 2022-07-17 2022-10-08 0000877422 sptn:MilitaryMember 2022-01-02 2022-10-08 0000877422 us-gaap:RetainedEarningsMember 2023-10-07 0000877422 sptn:WholesaleMember sptn:FreshMember 2022-07-17 2022-10-08 0000877422 us-gaap:RetainedEarningsMember 2023-04-23 2023-07-15 0000877422 us-gaap:CommonStockMember 2022-01-01 0000877422 sptn:RetailSegmentMember sptn:FreshMember 2022-01-02 2022-10-08 0000877422 sptn:CenterStoreMember sptn:RetailSegmentMember 2022-01-02 2022-10-08 0000877422 2023-11-07 0000877422 sptn:RetailSegmentMember sptn:FreshMember 2022-07-17 2022-10-08 0000877422 sptn:OtherProductMember sptn:RetailSegmentMember 2022-07-17 2022-10-08 0000877422 sptn:CurrentAccountsAndNotesReceivableMember 2022-12-31 0000877422 sptn:OtherProductMember 2023-01-01 2023-10-07 0000877422 us-gaap:OperatingSegmentsMember sptn:WholesaleMember 2023-07-16 2023-10-07 0000877422 sptn:CurrentAccountsAndNotesReceivableMember 2023-10-07 0000877422 us-gaap:OperatingSegmentsMember sptn:RetailSegmentMember 2022-07-17 2022-10-08 0000877422 us-gaap:BusinessRestructuringReservesMember 2023-07-16 2023-10-07 0000877422 2023-10-07 0000877422 sptn:CenterStoreMember sptn:RetailSegmentMember 2023-07-16 2023-10-07 0000877422 us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2022-07-17 2022-10-08 0000877422 us-gaap:PensionPlansDefinedBenefitMember sptn:SpartanNashMedicalPlanMember 2023-01-01 2023-10-07 0000877422 us-gaap:DefinedBenefitPostretirementHealthCoverageMember 2022-01-02 2022-10-08 0000877422 sptn:NonFoodMember 2022-07-17 2022-10-08 0000877422 2022-01-02 2022-10-08 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2023-04-23 2023-07-15 0000877422 sptn:NonFoodMember sptn:WholesaleMember 2022-07-17 2022-10-08 0000877422 sptn:LongTermNotesReceivableMember 2022-12-31 0000877422 sptn:IndividualsCustomerMember 2023-01-01 2023-10-07 0000877422 us-gaap:RestrictedStockMember 2022-01-02 2022-10-08 0000877422 sptn:FreshMember 2022-01-02 2022-10-08 0000877422 us-gaap:CommonStockMember 2023-07-16 2023-10-07 0000877422 sptn:CenterStoreMember sptn:RetailSegmentMember 2023-01-01 2023-10-07 0000877422 sptn:LeaseAndAncillaryCostsMember 2023-01-01 2023-10-07 0000877422 us-gaap:CommonStockMember 2022-04-24 2022-07-16 0000877422 us-gaap:RetainedEarningsMember 2022-01-02 2022-04-23 0000877422 2023-07-15 0000877422 2023-01-01 2023-04-22 0000877422 us-gaap:CommonStockMember 2023-07-15 0000877422 2022-04-24 2022-07-16 0000877422 srt:MaximumMember 2023-01-01 2023-10-07 0000877422 sptn:RetailSegmentMember sptn:FreshMember 2023-01-01 2023-10-07 0000877422 sptn:WholesaleMember sptn:FreshMember 2023-07-16 2023-10-07 0000877422 sptn:OtherCustomersMember 2023-07-16 2023-10-07 0000877422 sptn:WholesaleMember sptn:NationalAccountsMember 2023-07-16 2023-10-07 0000877422 sptn:WholesaleMember us-gaap:IntersegmentEliminationMember 2022-07-17 2022-10-08 0000877422 srt:FuelMember sptn:RetailSegmentMember 2023-07-16 2023-10-07 0000877422 sptn:SpartanNashMedicalPlanMember 2023-07-01 2023-07-01 0000877422 sptn:LongTermNotesReceivableMember 2022-10-08 0000877422 sptn:RetailSegmentMember 2022-07-17 2022-10-08 0000877422 sptn:WholesaleMember sptn:FreshMember 2023-01-01 2023-10-07 0000877422 us-gaap:CommonStockMember 2022-12-31 0000877422 2023-07-16 2023-10-07 0000877422 sptn:WholesaleMember us-gaap:IntersegmentEliminationMember 2023-07-16 2023-10-07 0000877422 sptn:RetailSegmentMember 2022-12-31 0000877422 us-gaap:RestrictedStockMember 2022-12-31 0000877422 us-gaap:CommonStockMember 2023-01-01 2023-04-22 0000877422 sptn:WholesaleMember 2022-12-31 0000877422 sptn:WholesaleMember sptn:OtherCustomersMember 2022-07-17 2022-10-08 0000877422 us-gaap:BusinessRestructuringReservesMember 2022-01-02 2022-10-08 0000877422 sptn:IndependentRetailersMember 2022-01-02 2022-10-08 0000877422 us-gaap:RetainedEarningsMember 2022-04-23 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2022-07-16 0000877422 sptn:IndividualsCustomerMember sptn:RetailSegmentMember 2023-01-01 2023-10-07 0000877422 sptn:CurrentAccountsAndNotesReceivableMember 2022-10-08 0000877422 sptn:WholesaleMember sptn:MilitaryMember 2022-01-02 2022-10-08 0000877422 us-gaap:RetainedEarningsMember 2023-07-16 2023-10-07 0000877422 sptn:WholesaleMember 2022-07-17 2022-10-08 0000877422 us-gaap:OperatingSegmentsMember sptn:RetailSegmentMember 2023-01-01 2023-10-07 0000877422 sptn:OtherCustomersMember sptn:RetailSegmentMember 2023-07-16 2023-10-07 0000877422 sptn:WholesaleMember 2022-01-02 2022-10-08 0000877422 sptn:LongTermNotesReceivableMember 2022-01-02 2022-10-08 0000877422 us-gaap:RestrictedStockMember 2023-10-07 0000877422 sptn:IndividualsCustomerMember sptn:RetailSegmentMember 2023-07-16 2023-10-07 0000877422 srt:FuelMember 2022-07-17 2022-10-08 0000877422 srt:FuelMember 2023-07-16 2023-10-07 0000877422 srt:FuelMember sptn:RetailSegmentMember 2022-01-02 2022-10-08 0000877422 sptn:RetailSegmentMember us-gaap:IntersegmentEliminationMember 2022-01-02 2022-10-08 0000877422 sptn:WholesaleMember sptn:OtherProductMember 2022-01-02 2022-10-08 0000877422 us-gaap:OperatingSegmentsMember sptn:RetailSegmentMember 2023-07-16 2023-10-07 0000877422 sptn:WarrantsOneMember sptn:NVInvestmentHoldingsMember sptn:CommercialAgreementMember 2020-10-07 0000877422 sptn:IndividualsCustomerMember 2022-07-17 2022-10-08 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2023-10-07 0000877422 us-gaap:CommonStockMember 2022-07-17 2022-10-08 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2023-01-01 2023-04-22 0000877422 sptn:OtherCustomersMember sptn:RetailSegmentMember 2023-01-01 2023-10-07 0000877422 us-gaap:CommonStockMember 2023-04-22 0000877422 2022-04-23 0000877422 sptn:OtherCustomersMember 2023-01-01 2023-10-07 0000877422 us-gaap:FinancialServiceMember 2023-01-12 2023-01-12 0000877422 sptn:AccumulatedOtherComprehensiveLossIncomeMember 2022-04-23 0000877422 sptn:WholesaleMember 2023-10-07 0000877422 sptn:IndividualsCustomerMember sptn:RetailSegmentMember 2022-07-17 2022-10-08 0000877422 sptn:IndependentRetailersMember 2022-07-17 2022-10-08 0000877422 sptn:WholesaleMember sptn:NationalAccountsMember 2022-01-02 2022-10-08 0000877422 2022-07-16 0000877422 sptn:WholesaleMember 2023-01-01 2023-10-07 0000877422 sptn:WholesaleMember sptn:OtherProductMember 2023-01-01 2023-10-07 0000877422 us-gaap:WarrantMember 2022-07-17 2022-10-08 0000877422 us-gaap:PerformanceSharesMember 2023-01-01 2023-10-07 0000877422 sptn:NationalAccountsMember 2023-01-01 2023-10-07 0000877422 sptn:CenterStoreMember 2023-07-16 2023-10-07 0000877422 sptn:CenterStoreMember sptn:WholesaleMember 2022-07-17 2022-10-08 sptn:Segment iso4217:USD xbrli:shares xbrli:pure xbrli:shares iso4217:USD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 7, 2023 .

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission File Number: 000-31127

img254361947_0.jpg

SPARTANNASH COMPANY

(Exact Name of Registrant as Specified in Its Charter)

Michigan

38-0593940

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

850 76 th Street, S.W.

P.O. Box 8700

Grand Rapids , Michigan

49518

(Address of Principal Executive Offices)

(Zip Code)

( 616 ) 878-2000

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock, no par value

SPTN

NASDAQ Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of November 7, 2023, the registrant had 34,623,737 outstanding shares of common stock, no par value.


FORWARD-LOOKING STATEMENTS

The matters discussed in this Quarterly Report on Form 10-Q, in the Company’s press releases, in the Company's website-accessible conference calls with analysts, and investor presentations include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), about the plans, strategies, objectives, goals or expectations of SpartanNash Company and subsidiaries (“SpartanNash” or “the Company”). These forward-looking statements may be identifiable by words or phrases indicating that the Company or management "expects," "projects," "anticipates," "plans," "believes," "intends," or "estimates," or that a particular occurrence or event "may," "could," "should," "will" or "will likely" result, occur or be pursued or "continue" in the future, that the "outlook", "trend", "guidance" or "target" is toward a particular result or occurrence, that a development is an "opportunity," "priority," "strategy," "focus," that the Company is "positioned" for a particular result, or similarly stated expectations.

Undue reliance should not be placed on the forward-looking statements contained in this Quarterly Report on Form 10-Q, SpartanNash’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and other periodic reports filed with the Securities and Exchange Commission (“SEC”), which speak only as of the date made. Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies may affect actual results and could cause actual results to differ materially. These risks and uncertainties include the Company's ability to compete in an extremely competitive industry; the Company's dependence on certain major customers; the Company's ability to implement its growth strategy and transformation initiatives; changes in relationships with the Company’s vendor base and supply chain disruptions; vulnerability to decreases in the supply and increases in the price of raw materials and labor, manufacturing, distribution and other costs; macroeconomic uncertainty, including rising inflation, potential economic recession, and increasing interest rates; difficulty attracting and retaining well-qualified Associates and effectively managing increased labor costs; customers to whom the Company extends credit or for whom the Company guarantees loans or lease obligations may fail to repay the Company; not achieving the Company’s strategy of growth through acquisitions and encountering difficulties successfully integrating acquired businesses that may not realize the anticipated benefits; the Company's ability to manage its private brand program for U.S. military commissaries, including the termination of the program or not achieving the desired results; disruptions to the Company's information security network, including security breaches and cyber-attacks; changes in the geopolitical conditions; instances of security threats, severe weather conditions and natural disasters; climate change and an increased focus by stakeholders on environmental sustainability and corporate responsibility; impacts to the Company’s business and reputation due to an increasing focus on environmental, social and governance matters; disruptions associated with disease outbreaks, such as the COVID-19 pandemic; impairment charges for goodwill or other long-lived assets; the Company's ability to successfully manage leadership transitions; interest rate fluctuations; the Company's ability to service its debt and to comply with debt covenants; the Company’s level of indebtedness; changes in government regulations; changes in the military commissary system, including its supply chain, or in the level of governmental funding; product recalls and other product-related safety concerns; labor relations issues; cost increases related to multi-employer pension plans and other postretirement plans; and other risks and uncertainties listed under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's most recent Annual Report on Form 10-K and in subsequent filings with the Securities and Exchange Commission.

This section and the discussions contained in Item 1A “Risk Factors” of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and in Part I, Item 2 “Critical Accounting Policies” of this Quarterly Report on Form 10-Q, are intended to provide meaningful cautionary statements for purposes of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. This should not be construed as a complete list of all the economic, competitive, governmental, technological and other factors that could adversely affect the Company’s expected consolidated financial position, results of operations or liquidity. Additional risks and uncertainties not currently known to SpartanNash or that SpartanNash currently believes are immaterial also may impair its business, operations, liquidity, financial condition and prospects. The Company undertakes no obligation to update or revise its forward-looking statements to reflect developments that occur, or information obtained after the date of this Quarterly Report. In addition, historical information should not be considered as an indicator of future performance.

2


TABLE OF CONTENTS

Page

PART I.

FINANCIAL INFORMATION

4

Item 1.

Financial Statements

4

Condensed Consolidated Balance Sheets

4

Condensed Consolidated Statements of Earnings

5

Condensed Consolidated Statements of Comprehensive Income

6

Condensed Consolidated Statements of Shareholders’ Equity

7

Condensed Consolidated Statements of Cash Flows

9

Notes to Condensed Consolidated Financial Statements

10

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

19

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

30

Item 4.

Controls and Procedures

30

PART II.

OTHER INFORMATION

30

Item 1.

Legal Proceedings

30

Item 1A.

Risk Factors

30

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

31

Item 6.

Exhibits

32

Signatures

33

3


PART I

FINANCIAL INFORMATION

ITEM 1. Financial Statements

SPARTANNASH COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, Unaudited)

October 7,

December 31,

2023

2022

Assets

Current assets

Cash and cash equivalents

$

17,554

$

29,086

Accounts and notes receivable, net

427,275

404,016

Inventories, net

579,631

571,065

Prepaid expenses and other current assets

63,594

62,244

Total current assets

1,088,054

1,066,411

Property and equipment, net

616,320

610,220

Goodwill

182,160

182,160

Intangible assets, net

102,661

106,341

Operating lease assets

251,426

257,047

Other assets, net

93,155

84,382

Total assets

$

2,333,776

$

2,306,561

Liabilities and Shareholders’ Equity

Current liabilities

Accounts payable

$

505,786

$

487,215

Accrued payroll and benefits

71,531

103,048

Other accrued expenses

53,267

62,465

Current portion of operating lease liabilities

43,372

45,453

Current portion of long-term debt and finance lease liabilities

8,410

6,789

Total current liabilities

682,366

704,970

Long-term liabilities

Deferred income taxes

78,318

66,293

Operating lease liabilities

231,809

239,062

Other long-term liabilities

28,212

33,376

Long-term debt and finance lease liabilities

535,804

496,792

Total long-term liabilities

874,143

835,523

Commitments and contingencies (Note 8)

Shareholders’ equity

Common stock, voting, no par value; 100,000 shares
authorized;
34,629 and 35,079 shares outstanding

457,830

468,061

Preferred stock, no par value, 10,000 shares authorized; no shares outstanding

Accumulated other comprehensive income

5,155

2,979

Retained earnings

314,282

295,028

Total shareholders’ equity

777,267

766,068

Total liabilities and shareholders’ equity

$

2,333,776

$

2,306,561

See accompanying notes to condensed consolidated financial statements.

4


SPARTANNASH COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

(In thousands, except per share amounts)

(Unaudited)

12 Weeks Ended

40 Weeks Ended

October 7, 2023

October 8, 2022

October 7, 2023

October 8, 2022

Net sales

$

2,264,248

$

2,296,512

$

7,484,036

$

7,334,060

Cost of sales

1,916,709

1,945,302

6,337,449

6,178,024

Gross profit

347,539

351,210

1,146,587

1,156,036

Operating expenses

Selling, general and administrative

322,796

333,373

1,059,787

1,094,422

Acquisition and integration, net

2,130

( 577

)

2,259

98

Restructuring and asset impairment, net

( 458

)

( 886

)

1,371

1,738

Total operating expenses

324,468

331,910

1,063,417

1,096,258

Operating earnings

23,071

19,300

83,170

59,778

Other expenses and (income)

Interest expense, net

9,280

6,051

30,218

14,764

Other, net

( 786

)

( 768

)

( 2,510

)

( 384

)

Total other expenses, net

8,494

5,283

27,708

14,380

Earnings before income taxes

14,577

14,017

55,462

45,398

Income tax expense

3,450

4,553

13,530

11,530

Net earnings

$

11,127

$

9,464

$

41,932

$

33,868

Net earnings per basic common share

$

0.33

$

0.27

$

1.22

$

0.96

Net earnings per diluted common share

$

0.32

$

0.26

$

1.20

$

0.93

Weighted average shares outstanding:

Basic

34,020

35,160

34,262

35,444

Diluted

34,523

36,145

34,967

36,398

See accompanying notes to condensed consolidated financial statements.

5


SPARTANNASH COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands, Unaudited)

12 Weeks Ended

40 Weeks Ended

October 7, 2023

October 8, 2022

October 7, 2023

October 8, 2022

Net earnings

$

11,127

$

9,464

$

41,932

$

33,868

Other comprehensive income (loss), before tax

Change in interest rate swap

3,625

4,770

Postretirement liability adjustment

( 720

)

( 687

)

( 1,957

)

6,601

Total other comprehensive income (loss), before tax

2,905

( 687

)

2,813

6,601

Income tax (expense) benefit related to items of other comprehensive income (loss)

( 673

)

168

( 637

)

( 1,619

)

Total other comprehensive income (loss), after tax

2,232

( 519

)

2,176

4,982

Comprehensive income

$

13,359

$

8,945

$

44,108

$

38,850

See accompanying notes to condensed consolidated financial statements.

6


SPARTANNASH COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In thousands, Unaudited)

Accumulated

Other

Shares

Common

Comprehensive

Retained

Outstanding

Stock

Income (Loss)

Earnings

Total

Balance at December 31, 2022

35,079

$

468,061

$

2,979

$

295,028

$

766,068

Net earnings

11,337

11,337

Other comprehensive loss

( 1,557

)

( 1,557

)

Dividends - $ 0.215 per share

( 7,679

)

( 7,679

)

Share repurchases

( 435

)

( 10,910

)

( 10,910

)

Stock-based compensation

5,147

5,147

Stock warrant

607

607

Issuances of common stock for associate stock purchase plan

17

358

358

Issuances of restricted stock

425

Cancellations of stock-based awards

( 151

)

( 3,917

)

( 3,917

)

Balance at April 22, 2023

34,935

$

459,346

$

1,422

$

298,686

$

759,454

Net earnings

19,468

19,468

Other comprehensive income

1,501

1,501

Dividends - $ 0.215 per share

( 7,524

)

( 7,524

)

Share repurchases

( 330

)

( 7,617

)

( 7,617

)

Stock-based compensation

2,465

2,465

Stock warrant

353

353

Issuances of common stock for associate stock purchase plan and other stock-based awards

18

328

328

Issuances of restricted stock

10

Cancellations of stock-based awards

( 15

)

( 31

)

( 31

)

Balance at July 15, 2023

34,618

$

454,844

$

2,923

$

310,630

$

768,397

Net earnings

11,127

11,127

Other comprehensive income

2,232

2,232

Dividends - $ 0.215 per share

( 7,475

)

( 7,475

)

Stock-based compensation

2,348

2,348

Stock warrant

319

319

Issuances of common stock for associate stock purchase plan

19

348

348

Issuances of restricted stock

11

Cancellations of stock-based awards

( 19

)

( 29

)

( 29

)

Balance at October 7, 2023

34,629

$

457,830

$

5,155

$

314,282

$

777,267

See accompanying notes to condensed consolidated financial statements.

7


SPARTANNASH COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY, CONTINUED

(In thousands, Unaudited)

Accumulated

Other

Shares

Common

Comprehensive

Retained

Outstanding

Stock

(Loss) Income

Earnings

Total

Balance at January 1, 2022

35,948

$

493,783

$

( 1,455

)

$

290,541

$

782,869

Net earnings

19,289

19,289

Other comprehensive income

23

23

Dividends - $ 0.21 per share

( 7,665

)

( 7,665

)

Stock-based compensation

4,295

4,295

Stock warrant

673

673

Issuances of common stock for associate stock purchase plan

3

108

108

Issuances of restricted stock

369

Cancellations of stock-based awards

( 180

)

( 4,288

)

( 4,288

)

Balance at April 23, 2022

36,140

$

494,571

$

( 1,432

)

$

302,165

$

795,304

Net earnings

5,115

5,115

Other comprehensive income

5,478

5,478

Dividends - $ 0.21 per share

( 7,561

)

( 7,561

)

Share repurchases

( 215

)

( 6,573

)

( 6,573

)

Stock-based compensation

1,397

1,397

Stock warrant

481

481

Issuance of common stock for associate stock purchase plan

4

104

104

Issuances of restricted stock

14

Cancellations of stock-based awards

( 30

)

( 23

)

( 23

)

Balance at July 16, 2022

35,913

$

489,957

$

4,046

$

299,719

$

793,722

Net earnings

9,464

9,464

Other comprehensive loss

( 519

)

( 519

)

Dividends - $ 0.21 per share

( 7,436

)

( 7,436

)

Share repurchases

( 543

)

( 16,716

)

( 16,716

)

Stock-based compensation

1,280

1,280

Stock warrant

505

505

Issuances of common stock for associate stock purchase plan

5

121

121

Issuances of restricted stock

4

Cancellations of stock-based awards

( 20

)

( 11

)

( 11

)

Balance at October 8, 2022

35,359

$

475,136

$

3,527

$

301,747

$

780,410

See accompanying notes to condensed consolidated financial statements.

8


SPARTANNASH COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, Unaudited)

40 Weeks Ended

October 7, 2023

October 8, 2022

Cash flows from operating activities

Net earnings

$

41,932

$

33,868

Adjustments to reconcile net earnings to net cash provided by operating activities:

Non-cash restructuring, asset impairment, and other charges

1,273

1,664

Depreciation and amortization

75,245

72,274

Non-cash rent

( 2,760

)

( 3,428

)

LIFO expense

22,445

42,916

Postretirement benefits income

( 1,990

)

( 367

)

Deferred income taxes

11,388

5,299

Stock-based compensation expense

9,960

6,972

Stock warrant

1,279

1,659

Loss (gain) on disposals of assets

304

( 68

)

Other operating activities

1,308

1,501

Changes in operating assets and liabilities:

Accounts receivable

( 23,071

)

( 68,142

)

Inventories

( 32,688

)

( 140,698

)

Prepaid expenses and other assets

( 3,558

)

( 2,043

)

Accounts payable

37,517

54,682

Accrued payroll and benefits

( 34,960

)

16,348

Current income taxes

( 3,564

)

( 350

)

Other accrued expenses and other liabilities

( 4,380

)

( 14,633

)

Net cash provided by operating activities

95,680

7,454

Cash flows from investing activities

Purchases of property and equipment

( 86,212

)

( 66,282

)

Net proceeds from the sale of assets

4,055

28,981

Acquisitions, net of cash acquired

( 780

)

( 9,408

)

Payments from customers on loans

1,097

1,103

Other investing activities

( 163

)

( 350

)

Net cash used in investing activities

( 82,003

)

( 45,956

)

Cash flows from financing activities

Proceeds from senior secured credit facility

1,044,242

1,057,633

Payments on senior secured credit facility

( 1,017,484

)

( 955,456

)

Repayment of other long-term debt and finance lease liabilities

( 6,279

)

( 5,116

)

Share repurchases

( 18,527

)

( 23,289

)

Net payments related to stock-based award activities

( 3,977

)

( 4,322

)

Dividends paid

( 22,381

)

( 22,458

)

Other financing activities

( 803

)

( 192

)

Net cash (used in) provided by financing activities

( 25,209

)

46,800

Net (decrease) increase in cash and cash equivalents

( 11,532

)

8,298

Cash and cash equivalents at beginning of period

29,086

10,666

Cash and cash equivalents at end of period

$

17,554

$

18,964

See accompanying notes to condensed consolidated financial statements.

9


SPARTANNASH COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Summary of Significant Accounting Policies and Basis of Presentation

The accompanying unaudited condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of SpartanNash Company and its subsidiaries (“SpartanNash” or “the Company”). Intercompany accounts and transactions have been eliminated. For further information, refer to the consolidated financial statements and footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

In the opinion of management, the accompanying condensed consolidated financial statements, taken as a whole, contain all adjustments, including normal recurring items, necessary to present fairly the financial position of SpartanNash as of October 7, 2023, and the results of its operations and cash flows for the interim periods presented. The preparation of the condensed consolidated financial statements and related notes to the financial statements requires management to make estimates. Estimates are based on historical experience, where applicable, and expectations of future outcomes which management believes are reasonable under the circumstances. Interim results are not necessarily indicative of results for a full year.

The unaudited information in the condensed consolidated financial statements for the third quarter and year-to-date periods of 2023 and 2022 include the results of operations of the Company for the 12- and 40-week periods ended October 7, 2023 and October 8, 2022 , respectively.

Note 2 – Adoption of New Accounting Standards and Recently Issued Accounting Standards

As of October 7, 2023 and for the period then ended, there were no recently adopted accounting standards that had a material impact on the Company’s condensed consolidated financial statements. There were no recently issued accounting standards not yet adopted which would have a material effect on the Company’s condensed consolidated financial statements.

10


Note 3 – Revenue

Disaggregation of Revenue

The following table provides information about disaggregated revenue by type of products and customers for each of the Company’s reportable segments:

12 Weeks Ended October 7, 2023

40 Weeks Ended October 7, 2023

(In thousands)

Wholesale

Retail

Total

Wholesale

Retail

Total

Type of products:

Center store (a)

$

623,273

$

256,550

$

879,823

$

2,054,415

$

832,202

$

2,886,617

Fresh (b)

488,929

243,198

732,127

1,651,191

811,825

2,463,016

Non-food (c)

465,473

120,149

585,622

1,535,880

386,993

1,922,873

Fuel

42,114

42,114

131,167

131,167

Other

24,325

237

24,562

79,562

801

80,363

Total

$

1,602,000

$

662,248

$

2,264,248

$

5,321,048

$

2,162,988

$

7,484,036

Type of customers:

Individuals

$

$

662,011

$

662,011

$

$

2,162,188

$

2,162,188

Independent retailers (d)

548,656

548,656

1,814,874

1,814,874

National accounts

504,971

504,971

1,741,407

1,741,407

Military (e)

538,790

538,790

1,729,221

1,729,221

Other

9,583

237

9,820

35,546

800

36,346

Total

$

1,602,000

$

662,248

$

2,264,248

$

5,321,048

$

2,162,988

$

7,484,036

12 Weeks Ended October 8, 2022

40 Weeks Ended October 8, 2022

(In thousands)

Wholesale

Retail

Total

Wholesale

Retail

Total

Type of products:

Center store (a)

$

642,552

$

259,044

$

901,596

$

2,010,150

$

806,116

$

2,816,266

Fresh (b)

508,440

253,712

762,152

1,647,860

811,879

2,459,739

Non-food (c)

450,974

106,074

557,048

1,466,281

342,015

1,808,296

Fuel

47,567

47,567

159,514

159,514

Other

27,903

246

28,149

89,442

803

90,245

Total

$

1,629,869

$

666,643

$

2,296,512

$

5,213,733

$

2,120,327

$

7,334,060

Type of customers:

Individuals

$

$

666,415

$

666,415

$

$

2,119,553

$

2,119,553

Independent retailers (d)

554,191

554,191

1,787,685

1,787,685

National accounts

552,980

552,980

1,785,704

1,785,704

Military (e)

508,102

508,102

1,596,612

1,596,612

Other

14,596

228

14,824

43,732

774

44,506

Total

$

1,629,869

$

666,643

$

2,296,512

$

5,213,733

$

2,120,327

$

7,334,060

(a) Center store includes dry grocery, frozen and beverages.

(b) Fresh includes produce, meat, dairy, deli, bakery, prepared proteins, seafood and floral.

(c) Non-food includes general merchandise, health and beauty care, tobacco products and pharmacy.

(d) Independent retailers include sales to manufacturers, brokers and distributors.

(e) Military represents the distribution of grocery products to U.S. military commissaries and exchanges, which primarily includes sales to manufacturers and brokers.

Contract Assets and Liabilities

Under its contracts with customers, the Company stands ready to deliver product upon receipt of a purchase order. Accordingly, the Company has no performance obligations under its contracts until its customers submit a purchase order. The Company does not receive pre-payment from its customers or enter into commitments to provide goods or services that have terms greater than one year . As the performance obligation is part of a contract that has an original expected duration of less than one year, the Company has applied the practical expedient under Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers , to omit disclosures regarding remaining performance obligations.

Revenue recognized from performance obligations related to prior periods (for example, due to changes in estimated rebates and incentives impacting the transaction price) was not material in any period presented.

For volume-based arrangements, the Company estimates the amount of the advanced funds earned by the retailers based on the expected volume of purchases by the retailer and amortizes the advances as a reduction of the transaction price and revenue earned. These advances are not considered contract assets under ASC 606 as they are not generated through the transfer of goods or services to the retailers. These advances are included in Other assets, net within the condensed consolidated balance sheets.

11


When the Company transfers goods or services to a customer, payment is due subject to normal terms and is not conditional on anything other than the passage of time. Typical payment terms range from "due upon receipt" to due within 30 days, depending on the customer. At contract inception, the Company expects that the period of time between the transfer of goods to the customer and when the customer pays for those goods will be less than one year, which is consistent with the Company’s standard payment terms. Accordingly, the Company has elected the practical expedient to not adjust for the effects of a significant financing component. As a result, these amounts are recorded as receivables and not contract assets. The Company had no contract assets for any period presented.

The Company does not typically incur incremental costs of obtaining a contract that are contingent upon successful contract execution and would therefore be capitalized.

Allowance for Credit Losses

Changes to the balance of the allowance for credit losses were as follows:

Allowance for Credit Losses

Current Accounts

Long-term

(In thousands)

and Notes Receivable

Notes Receivable

Total

Balance at December 31, 2022

$

6,098

$

948

$

7,046

Changes in credit loss estimates

( 1,314

)

439

( 875

)

Write-offs charged against the allowance

( 448

)

( 448

)

Balance at October 7, 2023

4,336

1,387

5,723

Allowance for Credit Losses

Current Accounts

Long-term

(In thousands)

and Notes Receivable

Notes Receivable

Total

Balance at January 1, 2022

$

4,414

$

731

$

5,145

Changes in credit loss estimates

903

903

Write-offs charged against the allowance

( 756

)

( 756

)

Balance at October 8, 2022

4,561

731

5,292

Note 4 – Goodwill and Other Intangible Assets

The Company has two reporting units, Wholesale and Retail. The carrying amount of goodwill recorded within the Wholesale reporting unit was $ 181.0 million and the value within the Retail reporting unit was $ 1.1 million as of both October 7, 2023 and December 31, 2022.

The Company has indefinite-lived intangible assets that are not amortized, consisting primarily of indefinite-lived trade names and liquor licenses. The carrying amount of indefinite-lived intangible assets was $ 67.8 million as of both October 7, 2023 and December 31, 2022.

The Company reviews goodwill and other indefinite-lived intangible assets for impairment annually, during the fourth quarter of each year, and more frequently if circumstances indicate impairment is probable. Such circumstances have not arisen in the current fiscal year. Testing goodwill and other indefinite-lived intangible assets for impairment requires management to make significant estimates about the Company’s future performance, cash flows, and other assumptions that can be affected by potential changes in economic, industry or market conditions, business operations, competition, or the Company’s stock price and market capitalization.

Note 5 – Restructuring and Asset Impairment

The following table provides the activity of reserves for closed properties for the 40-week period ended October 7, 2023. Included in the liability are lease-related ancillary costs from the date of closure to the end of the remaining lease term, as well as related severance. Reserves for closed properties recorded in the condensed consolidated balance sheets are included in “Other accrued expenses” in Current liabilities and “Other long-term liabilities” in Long-term liabilities based on the timing of when the obligations are expected to be paid. Reserves for severance are recorded in “Accrued payroll and benefits”.

Reserves for Closed Properties

Lease

Ancillary

(In thousands)

Costs

Severance

Total

Balance at December 31, 2022

$

3,977

$

$

3,977

Provision for severance

21

21

Changes in estimates

( 228

)

( 228

)

Accretion expense

83

83

Payments

( 836

)

( 21

)

( 857

)

Balance at October 7, 2023

$

2,996

$

$

2,996

12


Restructuring and asset impairment, net in the condensed consolidated statements of earnings consisted of the following:

12 Weeks Ended

40 Weeks Ended

October 7,

October 8,

October 7,

October 8,

(In thousands)

2023

2022

2023

2022

Asset impairment charges (a)

$

$

752

$

3,745

$

4,232

Provision for closing charges

857

857

Loss (gain) on sales of assets related to closed facilities (b)

120

( 2,553

)

( 2,470

)

( 3,168

)

Provision for severance

1

21

9

Other (income) costs associated with site closures (c)

( 4

)

58

596

( 17

)

Lease termination adjustments (d)

( 102

)

Changes in estimates (e)

( 575

)

( 521

)

( 73

)

Total

$

( 458

)

$

( 886

)

$

1,371

$

1,738

(a) Asset impairment charges in the current year relate to two store closures within the Retail segment and impairment losses related to a distribution location that sustained significant storm damage within the Wholesale segment. In the prior year, asset impairment charges were incurred in the Retail segment and related to restructuring of the Retail segment's e-commerce delivery model and a store closure.

(b) Loss (gain) on sales of assets in the current year primarily relate to the sale of a store within the Retail segment. Gains on sales of assets in the prior year relates to the sales of real property of previously closed locations within the Wholesale and Retail segments.

(c) Other costs net activity in the current year primarily relate to Retail store closings. In the prior year, activity primarily relates to restructuring activity within the Wholesale segment and Retail store closings.

(d) Lease termination adjustments in the prior year relate to the gain recognized to terminate a lease agreement.

(e) Changes in estimates primarily relate to revised estimates for turnover and other lease ancillary costs associated with previously closed locations. The current quarter also included a $ 0.3 million gain for additional insurance proceeds received related to a distribution location that sustained significant storm damage within the Wholesale segment.

Long-lived assets which are not recoverable are measured at fair value on a nonrecurring basis using Level 3 inputs under the fair value hierarchy, as further described in Note 6. In the current year, assets with a book value of $ 7.4 million were measured at a fair value of $ 3.7 million, resulting in impairment charges of $ 3.7 million . In the prior year, long-lived assets with a book value of $ 4.3 million were measured at a fair value of $ 0.1 million, resulting in impairment charges of $ 4.2 million. The fair value of long-lived assets is determined by estimating the amount and timing of net future cash flows, including the expected proceeds from the sale of assets and expected insurance recoveries, discounted using a risk-adjusted rate of interest. The Company estimates future cash flows based on historical results of operations, external factors expected to impact future performance, experience and knowledge of the geographic area in which the assets are located, and when necessary, uses the support of real estate brokers.

Note 6 – Fair Value Measurements

ASC 820, Fair Value Measurement , prioritizes the inputs to valuation techniques used to measure fair value into the following hierarchy:

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3: Unobservable inputs for the asset or liability, reflecting the reporting entity’s own assumptions about the assumptions that market participants would use in pricing.

Financial instruments include cash and cash equivalents, accounts and notes receivable, accounts payable and long-term debt. The carrying amounts of cash and cash equivalents, accounts and notes receivable, and accounts payable approximate fair value because of the short-term maturities of these financial instruments. For discussion of the fair value measurements related to goodwill, and long- or indefinite-lived asset impairment charges, refer to Notes 4 and 5. At October 7, 2023 and December 31, 2022, the book value and estimated fair value of the Company’s debt instruments, excluding debt financing costs, were as follows:

October 7,

December 31,

(In thousands)

2023

2022

Book value of debt instruments, excluding debt financing costs:

Current maturities of long-term debt and finance lease liabilities

$

8,410

$

6,789

Long-term debt and finance lease liabilities

540,147

501,419

Total book value of debt instruments

548,557

508,208

Fair value of debt instruments, excluding debt financing costs

545,025

507,668

Deficit of fair value over book value

$

( 3,532

)

$

( 540

)

13


The estimated fair value of debt is based on market quotes for instruments with similar terms and remaining maturities (Level 2 inputs and valuation techniques).

The Company's interest rate swap agreement is considered a Level 2 instrument. The Company values the interest rate swap using standard models and observable market inputs including SOFR interest rates and discount rates, which are considered Level 2 inputs. The location and the fair value of the interest rate swap agreement in the condensed consolidated balance sheet is disclosed in Note 7.

Note 7 – Derivatives

Hedging of Interest Rate Risk

During the first quarter of 2023, the Company entered into an interest rate swap contract to mitigate its exposure to changes in variable interest rates. The Company's interest rate swap is designated as a cash flow hedge as of both the effective date, March 17, 2023, and as of October 7, 2023. The interest rate swap is reflected at its fair value in the condensed consolidated balance sheets. Refer to Note 6 for further information on the fair value of the interest rate swap.

Details of the pay-fixed, receive-floating interest rate swap contract as of October 7, 2023 are as follows:

Effective Date

Maturity Date

Notional Value
(in millions)

Pay Fixed Rate

Receive Floating Rate

Floating Rate Reset Terms

March 17, 2023

November 17, 2027

$ 150

3.646 %

One-Month CME Term SOFR

Monthly

The Company performed an initial quantitative assessment of hedge effectiveness using the change-in-variable-cash-flows method. Under this method, the Company assessed the effectiveness of the hedging relationship by comparing the present value of the cumulative change in the expected future cash flows on the variable leg of the interest rate swap with the present value of the cumulative change in the expected future interest cash flows on the variable-rate debt. The Company determined the interest rate swap to be highly effective. To assess for continued hedge effectiveness, the Company performs a retrospective and prospective qualitative assessment each quarter. The Company also monitors the credit risk of the counterparty on an ongoing basis. The change in the fair value of the interest rate swap is initially reported in "Other comprehensive income" in the condensed consolidated statements of comprehensive income and subsequently reclassified to earnings in "Interest expense, net" in the condensed consolidated statements of earnings when the hedged transactions affect earnings.

The location and the fair value of the interest rate swap in the condensed consolidated balance sheets as of October 7, 2023 is as follows:

Derivative Fair Value

October 7,

(In thousands)

Condensed Consolidated Balance Sheet Location

2023

Cash Flow Hedge:

Interest rate swap

Prepaid expenses and other current assets

$

2,489

Interest rate swap

Other assets, net

2,344

Interest rate swap

Accumulated other comprehensive income

3,652

The location and amount of gains recognized in the condensed consolidated statements of earnings for the interest rate swap, presented on a pre-tax basis, are as follows:

12 Weeks Ended

40 Weeks Ended

October 7,

October 7,

2023

2023

(In thousands)

Interest expense, net

Interest expense, net

Total amounts of expense line items presented in the condensed consolidated statements of
earnings in which the effects of cash flow hedges are recorded

$

9,280

$

30,218

Gain on cash flow hedging relationships:

Gain reclassified from comprehensive income into earnings

573

1,242

Note 8 – Commitments and Contingencies

The Company is engaged from time-to-time in routine legal proceedings incidental to its business. The Company does not believe that these routine legal proceedings, taken as a whole, will have a material impact on its business or financial condition. While the ultimate effect of such actions cannot be predicted with certainty, management believes that their outcome will not result in an adverse effect on the Company’s consolidated financial position, operating results or liquidity.

14


The Company has contributed and is required to continue making contributions to the Central States Southeast and Southwest Pension Fund (the “Central States Plan” or the “Plan”), a multi-employer pension plan, based on obligations arising from certain of its collective bargaining agreements. If the Company were to cease making such contributions and triggered a withdrawal from the Plan, it is possible that the Company would be obligated to pay a withdrawal liability to the Plan if the Plan is underfunded at the time of such withdrawal.

On March 10, 2021, the United States Congress passed the American Rescue Plan Act of 2021 (the “Act”), which provides financial relief to certain failing multiemployer pension plans. On January 12, 2023, the Central States Plan received approximately $ 35.8 billion in Special Financial Assistance (“SFA”), inclusive of interest, which is designed to alleviate the risk of insolvency of the Plan.

Based on the most recent information available to the Company, management believes the value of assets held in trust to pay benefits covers the present value of actuarial accrued liabilities in the Central States Plan. Except with respect to the approved SFA, management is not aware of any significant change in funding levels in the Plan since December 31, 2022. Due to uncertainty regarding future factors that could trigger a withdrawal liability, as well as the absence of specific information regarding matters such as the Plan’s current financial situations, the Company is unable to determine with certainty the current amount of the Plan’s funding and/or SpartanNash’s current potential withdrawal liability exposure in the event of a future withdrawal from the Plan. Any adjustment for withdrawal liability would be recorded when it is probable that a liability exists and can be reasonably determined.

Note 9 – Associate Retirement Plans

During the 12- and 40- week periods ended October 7, 2023 , the Company recognized net periodic postretirement benefit income of $ 0.7 million and $ 2.2 million, respectively, related to the SpartanNash Retiree Medical Plan (“Retiree Medical Plan” or "Plan"). During the 12- and 40- week periods ended October 8, 2022 the Company recognized net periodic postretirement benefit income of $ 0.7 million and expense of $ 0.2 million, respectively, related to the Retiree Medical Plan.

Effective June 30, 2022, the Company has amended the Retiree Medical Plan. In connection with the amendment, the Company will make lump sum cash payments to all active and retired participants in lieu of future monthly benefits and reimbursements previously offered under the Plan. As a result of the amendment effective June 30, 2022, the Plan obligation was remeasured, resulting in a reduction to the obligation of $ 6.6 million and a corresponding prior service credit in AOCI, which will be amortized to net periodic postretirement benefit income over the remaining period until the final payment on July 1, 2024. During the 12- and 40- week periods ended October 7, 2023 , the Company recognized $ 0.8 million and $ 2.5 million in net periodic postretirement benefit income related to the amortization of the prior service credit from AOCI. During the 12- and 40- week periods ended October 8, 2022 , the Company recognized $ 0.8 million and $ 0.9 million in net periodic postretirement benefit income related to the amortization of the prior service credit from AOCI.

On July 1, 2023 and July 1, 2022, the Company made lump sum payments to retired participants totaling $ 1.3 million and $ 2.0 million, respectively. The payments constituted partial settlements of the Plan, which resulted in the recognition within net periodic postretirement expense of $ 0.3 million and $ 0.7 million on July 1, 2023 and July 1, 2022, respectively, related to the net actuarial loss within AOCI. The remaining payment, which relates to active participants, is expected to be made on or about July 1, 2024.

The Company’s retirement programs also include defined contribution plans providing contributory benefits, as well as executive compensation plans for a select group of management personnel and/or highly compensated associates.

In the first quarter of the prior year, the Company realized a gain of $ 0.2 million related to a refund from the annuity provider associated with an ineligible participant previously included in the terminated SpartanNash Company Pension Plan. These amounts are included in “Other, net” in the condensed consolidated statements of earnings.

Multi-Employer Plans

In addition to the plans listed above, the Company participates in the Central States Southeast and Southwest Pension Fund, the Michigan Conference of Teamsters and Ohio Conference of Teamsters Health and Welfare plans (collectively referred to as “multi-employer plans”), and other company-sponsored defined contribution plans for most associates covered by collective bargaining agreements.

With respect to the Company’s participation in the Central States Plan, expense is recognized as contributions are payable. The Company’s contributions during the 12- week periods ended October 7, 2023 and October 8, 2022 were $ 2.3 million and $ 2.2 million, respectively. The Company's contributions during the 40-week periods ended October 7, 2023 and October 8, 2022 were $ 9.8 million and $ 9.1 million, respectively. See Note 8 for further information regarding contingencies related to the Company’s participation in the Central States Plan.

Note 10 – Income Taxes

The effective income tax rate was 23.7 % and 32.5 % for the 12 weeks ended October 7, 2023 and October 8, 2022, respectively. The effective income tax rate was 24.4 % and 25.4 % for the 40 weeks ended October 7, 2023 and October 8, 2022, respectively.

15


The difference from the federal statutory rate in the current year and prior year quarters were primarily due to state taxes and non-deductible expenses, partially offset by benefits associated with federal tax credits. The difference from the federal statutory rate in the current year was primarily due to state taxes and non-deductible expenses, partially offset by benefits associated with federal tax credits, discrete tax benefits due to a change in contingencies and discrete tax benefits related to stock compensation. The difference in the federal statutory rate in the prior year was primarily due to state taxes, limitations on the deductibility of executive compensation and non-deductible expenses, partially offset by benefits associated with federal tax credits and discrete tax benefits related to stock compensation.

Note 11 – Stock-Based Compensation

Stock-Based Employee Awards

The Company sponsors shareholder-approved stock incentive plans that provide for the granting of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance share units, dividend equivalent rights, and other stock-based and stock-related awards to directors, officers and other key associates.

Stock -based compensation expense recognized and included in “Selling, general and administrative expenses” in the condensed consolidated statements of earnings, and related tax impacts were as follows:

12 Weeks Ended

40 Weeks Ended

(In thousands)

October 7, 2023

October 8, 2022

October 7, 2023

October 8, 2022

Restricted stock expense

$

1,771

$

1,280

$

8,468

$

6,972

Performance share unit expense

577

1,492

Income tax benefit

( 593

)

( 582

)

( 3,502

)

( 3,630

)

Stock-based compensation expense, net of tax

$

1,755

$

698

$

6,458

$

3,342

The following table summarizes activity in the stock incentive plans for the 40 weeks ended October 7, 2023:

Weighted

Weighted

Restricted

Average

Performance

Average

Stock

Grant-Date

Share Unit

Grant-Date

Awards

Fair Value

Awards

Fair Value

Outstanding at December 31, 2022

863,063

$

22.05

$

Granted

445,762

26.97

299,840

27.01

Vested

( 432,150

)

21.16

Cancelled/Forfeited

( 38,062

)

26.22

( 2,803

)

27.24

Outstanding at October 7, 2023

838,613

$

24.94

297,037

$

27.01

As of October 7, 2023 , total unrecognized compensation cost related to nonvested restricted stock awards granted under the Company’s stock incentive plans is $ 11.1 million and is expected to be recognized over a weighted average period of 1.9 years. As of October 7, 2023 , total unrecognized compensation cost related to nonvested performance share unit awards granted under the Company’s stock incentive plans is $ 6.5 million and is expected to be recognized over a weighted average period of 2.2 years.

Stock Warrant

On October 7, 2020, in connection with its entry into a commercial agreement with Amazon.com, Inc. (“Amazon”), the Company issued Amazon.com NV Investment Holdings LLC, a subsidiary of Amazon, a warrant to acquire up to an aggregate of 5,437,272 shares of the Company’s common stock (the “Warrant”), subject to certain vesting conditions. Warrant shares totaling 1,087,455 shares vested upon the signing of the commercial agreement and had a grant date fair value of $ 5.51 per share. Warrant shares totaling up to 4,349,817 shares may vest in connection with conditions defined by the terms of the Warrant, as Amazon makes payments to the Company in connection with the commercial supply agreement, in increments of $ 200 million, and had a grant date fair value of $ 5.33 per share. Upon vesting, shares may be acquired at an exercise price of $ 17.7257 . The Warrant contains customary anti-dilution, down-round and change-in-control provisions. The right to purchase shares in connection with the Warrant expires on October 7, 2027 .

Share-based payment expense recognized as a reduction of “Net sales” in the condensed consolidated statements of earnings, and related tax benefits were as follows:

12 Weeks Ended

40 Weeks Ended

(In thousands)

October 7, 2023

October 8, 2022

October 7, 2023

October 8, 2022

Warrant expense

$

319

$

505

$

1,279

$

1,659

Income tax benefit

( 43

)

( 46

)

( 138

)

( 187

)

Warrant expense, net of tax

$

276

$

459

$

1,141

$

1,472

16


The following table summarizes stock warrant activity for the 40 weeks ended October 7, 2023:

Warrant

Outstanding and nonvested at December 31, 2022

3,479,849

Vested

( 217,492

)

Outstanding and nonvested at October 7, 2023

3,262,357

As of October 7, 2023 , total unrecognized cost related to nonvested warrant shares was $ 17.2 million, which may be expensed as vesting conditions are satisfied over the remaining term of the agreement, or 4.0 years. Warrants representing 2,174,915 shares are vested and exercisable. As of October 7, 2023 , nonvested warrant shares had an intrinsic value of $ 17.1 million, and vested warrant shares had an intrinsic value of $ 11.4 million.

Note 12 – Earnings Per Share

Outstanding nonvested restricted stock awards under the 2015 Stock Incentive Plan contain nonforfeitable rights to dividends or dividend equivalents, which participate in undistributed earnings with common stock. These awards are classified as participating securities and are included in the calculation of basic earnings per share. Awards under the 2020 Stock Incentive Plan do not contain nonforfeitable rights to dividends or dividend equivalents and are therefore not classified as participating securities. The dilutive impact of both the restricted stock awards and warrants are presented below, as applicable. Weighted average restricted stock awards that were not included in the EPS calculations because they were anti-dilutive were 288,041 and 18,340 for the 12- and 40- week periods ended October 7, 2023, respectively. The performance share units are not currently dilutive. The following table sets forth the computation of basic and diluted net earnings per share:

12 Weeks Ended

40 Weeks Ended

(In thousands, except per share amounts)

October 7, 2023

October 8, 2022

October 7, 2023

October 8, 2022

Numerator:

Net earnings

$

11,127

$

9,464

$

41,932

$

33,868

Adjustment for earnings attributable to participating securities

( 81

)

( 100

)

( 333

)

( 406

)

Net earnings used in calculating earnings per share

$

11,046

$

9,364

$

41,599

$

33,462

Denominator:

Weighted average shares outstanding, including participating securities

34,020

35,160

34,262

35,444

Adjustment for participating securities

( 247

)

( 370

)

( 272

)

( 425

)

Shares used in calculating basic earnings per share

33,773

34,790

33,990

35,019

Effect of dilutive stock warrant

432

792

614

784

Effect of dilutive restricted stock awards

72

193

91

170

Shares used in calculating diluted earnings per share

34,277

35,775

34,695

35,973

Basic earnings per share

$

0.33

$

0.27

$

1.22

$

0.96

Diluted earnings per share

$

0.32

$

0.26

$

1.20

$

0.93

Note 13 – Supplemental Cash Flow Information

Supplemental cash flow information is as follows:

40 Weeks Ended

(In thousands)

October 7, 2023

October 8, 2022

Non-cash investing activities:

Capital expenditures included in accounts payable

$

6,458

$

6,341

Operating lease asset additions

34,815

16,227

Finance lease asset additions

13,492

16,204

Non-cash financing activities:

Recognition of operating lease liabilities

34,815

16,227

Recognition of finance lease liabilities

13,492

16,204

Other supplemental cash flow information:

Cash paid for interest

30,930

13,008

17


Note 14 – Segment Information

The following tables set forth information about the Company by reportable segment:

(In thousands)

Wholesale

Retail

Total

12 Weeks Ended October 7, 2023

Net sales to external customers

$

1,602,000

$

662,248

$

2,264,248

Inter-segment sales

274,540

434

274,974

Acquisition and integration

65

2,065

2,130

Restructuring and asset impairment, net

( 293

)

( 165

)

( 458

)

Depreciation and amortization

12,151

10,891

23,042

Operating earnings

18,153

4,918

23,071

Capital expenditures

16,287

9,101

25,388

12 Weeks Ended October 8, 2022

Net sales to external customers

$

1,629,869

$

666,643

$

2,296,512

Inter-segment sales

280,892

274

281,166

Acquisition and integration, net

( 577

)

( 577

)

Restructuring and asset impairment, net

( 2,088

)

1,202

( 886

)

Depreciation and amortization

11,090

10,743

21,833

Operating earnings

14,015

5,285

19,300

Capital expenditures

9,642

10,209

19,851

40 Weeks Ended October 7, 2023

Net sales to external customers

$

5,321,048

$

2,162,988

$

7,484,036

Inter-segment sales

902,720

1,086

903,806

Acquisition and integration

189

2,070

2,259

Restructuring and asset impairment, net

688

683

1,371

Depreciation and amortization

39,165

36,080

75,245

Operating earnings

66,020

17,150

83,170

Capital expenditures

54,512

31,700

86,212

40 Weeks Ended October 8, 2022

Net sales to external customers

$

5,213,733

$

2,120,327

$

7,334,060

Inter-segment sales

904,144

675

904,819

Acquisitions and integration, net

98

98

Restructuring and asset impairment, net

( 2,216

)

3,954

1,738

Depreciation and amortization

36,602

35,672

72,274

Operating earnings

54,834

4,944

59,778

Capital expenditures

34,867

31,415

66,282

(In thousands)

October 8, 2023

December 31, 2022

Total Assets

Wholesale

$

1,573,915

$

1,525,760

Retail

759,861

780,801

Total

$

2,333,776

$

2,306,561

18


ITEM 2. Management’s Discussion and Analysis of Fina ncial Condition and Results of Operations

This Management’s Discussion and Analysis of financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements contained in this Quarterly Report on Form 10-Q, the information contained under the caption “Forward-Looking Statements,” which appears at the beginning of this report, and the information in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

Overview

SpartanNash, headquartered in Grand Rapids, Michigan, is a food solutions company that delivers the ingredients for a better life. Its core businesses include distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a premier fresh produce distribution network and the Our Family® private label brand. SpartanNash serves customer locations in all 50 states and the District of Columbia, Europe, Cuba, Puerto Rico, Honduras, Iraq, Kuwait, Bahrain, Qatar, Djibouti, Korea and Japan.

The Company’s Wholesale segment provides a wide variety of nationally branded and private brand grocery products and perishable food products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company’s corporate owned retail store. The Company’s Wholesale segment also distributes grocery products to 160 military commissaries and over 400 exchanges worldwide. The Company is the exclusive supplier of private brand products to U.S. military commissaries, a partnership with DeCA which began in fiscal 2017.

As of the end of the third quarter, the Company’s Retail segment operated 144 corporate owned retail stores in the Midwest region primarily under the banners of Family Fare, Martin’s Super Markets and D&W Fresh Market. The Company also offered pharmacy services in 91 of its corporate owned retail stores (81 of the pharmacies are owned by the Company), operated three pharmacy locations not associated with corporate-owned retail locations and operated 36 fuel centers. The Company’s neighborhood market strategy distinguishes its corporate owned retail stores from supercenters and limited assortment stores.

All fiscal quarters are 12 weeks, except for the Company’s first quarter, which is 16 weeks and will generally include the Easter holiday. The fourth quarter includes the Thanksgiving and Christmas holidays, and depending on the fiscal year end, may include the New Year’s holiday.

The majority of the Company’s revenues are not seasonal in nature. However, in some geographies, corporate retail stores and independent retail customers are dependent on tourism, and therefore can be affected by seasons. The Company's revenues may also be impacted by weather patterns.

2023 Third Quarter Highlights

Key financial and operational highlights for the third quarter include the following:

Net sales of $2.26 billion, a decrease of 1.4%, compared to $2.30 billion in the prior year quarter.
Retail comparable store sales increased 1.2% compared to the prior year quarter.
Net earnings of $11.1 million, compared to $9.5 million in the prior year quarter.
Adjusted EBITDA of $60.9 million, compared to $57.3 million in the prior year quarter.
Cash generated from operating activities was $95.7 million during the year-to-date period of fiscal 2023 compared to $7.5 million in the year-to-date period of the prior year.
Returned $40.9 million to shareholders during the year-to-date period of fiscal 2023 through $18.5 million in share repurchases and $22.4 million in dividends.

The Company believes that certain known or anticipated trends may cause future results to vary from historical results. The Company believes certain initiatives tied to its long-term plan including the supply chain transformation, merchandising transformation, and refreshed go-to-market strategy will favorably impact future results. The Company anticipates that additional investments in capital expenditures, and increased borrowings from the Company's senior secured credit facility, will be necessary to support these and other programs. Offsetting the Company's expectations of favorable future results are macroeconomic headwinds including economic uncertainty associated with inflation, labor costs, and interest rates. The Company continues to be exposed to inflationary impacts to other general areas including utilities, insurance and fuel costs.

19


Results of Operations

The following table sets forth items from the condensed consolidated statements of earnings as a percentage of net sales and the year-to-year percentage change in the dollar amounts:

Percentage of Net Sales

Percentage Change

12 Weeks Ended

40 Weeks Ended

12 Weeks Ended

40 Weeks Ended

October 7, 2023

October 8, 2022

October 7, 2023

October 8, 2022

October 7, 2023

October 7, 2023

Net sales

100.0

100.0

100.0

100.0

(1.4

)

2.0

Gross profit

15.3

15.3

15.3

15.8

(1.0

)

(0.8

)

Selling, general and administrative

14.3

14.5

14.2

14.9

(3.2

)

(3.2

)

Acquisition and integration, net

0.1

(0.0

)

0.0

0.0

**

**

Restructuring charges and asset impairment, net

(0.0

)

(0.0

)

0.0

0.0

(48.3

)

(21.1

)

Operating earnings

1.0

0.8

1.1

0.8

19.5

39.1

Other expenses

0.4

0.2

0.4

0.2

60.8

92.7

Earnings before income taxes

0.6

0.6

0.7

0.6

4.0

22.2

Income tax expense

0.2

0.2

0.2

0.2

(24.2

)

17.3

Net earnings

0.5

0.4

0.6

0.5

17.6

23.8

Note: Certain totals do not sum due to rounding.

** Not meaningful

Net Sales The following table presents net sales by segment and variances in net sales:

12 Weeks Ended

40 Weeks Ended

(In thousands)

October 7, 2023

October 8, 2022

Variance

October 7, 2023

October 8, 2022

Variance

Wholesale

$

1,602,000

$

1,629,869

$

(27,869

)

$

5,321,048

$

5,213,733

$

107,315

Retail

662,248

666,643

(4,395

)

2,162,988

2,120,327

42,661

Total net sales

$

2,264,248

$

2,296,512

$

(32,264

)

$

7,484,036

$

7,334,060

$

149,976

Net sales for the quarter ended October 7, 2023 (the “third quarter”) decreased $32.3 million, or 1.4%, to $2.26 billion from $2.30 billion in the quarter ended October 8, 2022 (the “prior year quarter”). Net sales for the year-to-date period ended October 7, 2023 (the "year-to-date period") increased $150.0 million, or 2.0%, to $7.48 billion from $7.33 billion in the year-to-date period ended October 8, 2022 (the "prior year-to-date-period"). The decrease during the current quarter reflected sales declines in both the Wholesale and Retail segments, which were unfavorably impacted by a reduction in volume and partially offset by higher pricing from inflationary trends. The year-to-date increase reflected sales growth in both the Wholesale and Retail segments, which were favorably impacted by higher pricing from inflationary trends and partially offset by lower volumes.

Wholesale net sales decreased $27.9 million, or 1.7% to $1.60 billion in the third quarter from $1.63 billion in the prior year quarter. Wholesale net sales for the year-to-date period increased $107.3 million, or 2.1%, to $5.32 billion from $5.21 billion in the prior year-to-date period. The decrease in the current quarter was due primarily to marketplace demand changes from a certain national account customer. The increase in the year-to-date period was primarily due to the inflationary impact on pricing, partially offset by a decrease led by marketplace demand changes from a certain national account customer. Overall case volumes for the segment were down in the current quarter and current year-to-date period compared to the prior year by 5.4% and 4.2%, respectively.

Retail net sales decreased $4.4 million, or 0.7%, to $662.2 million in the third quarter from $666.6 million in the prior year quarter. Net sales for the year-to-date period increased $42.7 million, or 2.0%, to $2.16 billion from $2.12 billion in the prior year-to-date period. Comparable store sales grew 1.2% and 3.6% for the current quarter and current year-to-date periods, respectively. The comparable store sales growth was due primarily to the inflationary impact on pricing, which included an offsetting 6.0% and 5.8% decline in unit volumes in the current quarter and current year-to-date periods, respectively. Additionally, lower fuel sales reduced reported net sales by 0.8% and 1.3% in the current quarter and current year-to-date periods, respectively. The Company defines a retail store as comparable when it is in operation for 14 accounting periods (a period equals four weeks), regardless of remodels, expansions, or relocated stores. Acquired stores are included in the comparable sales calculation 13 periods after the acquisition date. Sales are compared to the same store’s operations from the prior year period for purposes of calculation of comparable store sales. Fuel is excluded from the comparable sales calculation due to volatility in price. Comparable store sales is a widely used metric among retailers, which is useful to management and investors to assess performance. The Company’s definition of comparable store sales may differ from similarly titled measures at other companies.

20


Gross Profit – Gross profit represents net sales less cost of sales, which for all non-production operations includes purchase costs, in-bound freight, physical inventory adjustments, markdowns and promotional allowances and excludes warehousing costs, depreciation and other administrative expenses. The Company’s gross profit definition may not be identical to similarly titled measures reported by other companies. Vendor allowances that relate to the buying and merchandising activities consist primarily of promotional allowances, which are generally allowances on purchased quantities and, to a lesser extent, slotting allowances, which are billed to vendors for the Company’s merchandising costs, such as setting up warehouse infrastructure. Vendor allowances are recognized as a reduction in cost of sales when the product is sold. Lump sum payments received for multi-year contracts are amortized over the life of the contracts based on contractual terms. The Wholesale segment includes shipping and handling costs in the Selling, general and administrative section of operating expenses in the consolidated statements of earnings.

Gross profit decreased $3.7 million, or 1.0%, to $347.5 million in the third quarter from $351.2 million in the prior year quarter. As a percent of net sales, gross profit for the current quarter was 15.35% compared to 15.29% in the prior year quarter. The gross profit decline was driven by lower volumes. The gross profit rate increase in the current quarter was driven by lower last-in-first-out ("LIFO") expense and benefits realized from the merchandising transformation initiative. These benefits were mostly offset by the anticipated lower inflation-related price change benefits in the Wholesale segment compared to elevated levels in the prior year quarter and lower pharmacy margins in the Retail segment. LIFO expense decreased $8.3 million, or 36 basis points, compared to the prior year quarter. Gross profit for the year-to-date period decreased $9.4 million, or 0.8% from $1.16 billion in the prior year-to-date period to $1.15 billion in the current year. As a percent of net sales, gross profit for the year-to-date period was 15.32% compared to 15.76% in the prior year-to-date period. The gross profit decline was driven by lower volumes. In addition, the gross profit rate decrease in the year-to-date period was driven by lower inflation-related price change benefits in the Wholesale segment compared to elevated levels in the prior year, partially offset by benefits realized from the merchandising transformation initiative and a decline in LIFO expense. LIFO expense decreased $20.5 million, or 29 basis points, compared to the prior year-to-date period.

Selling, General and Administrative Expenses – Selling, general and administrative (“SG&A”) expenses consist primarily of operating costs related to retail and supply chain operations, including salaries and wages, employee benefits, facility costs, shipping and handling, equipment rental, depreciation, and out-bound freight, in addition to corporate administrative expenses.

SG&A expenses for the third quarter decreased $10.6 million, or 3.2%, to $322.8 million from $333.4 million in the prior year quarter, representing 14.3% of net sales in the third quarter compared to 14.5% in the prior year quarter. SG&A expense for the year-to-date period decreased $34.6 million, or 3.2% to $1.06 billion, from $1.09 billion in the prior year-to-date period, representing 14.2% in the current year-to-date period compared to 14.9% as a percentage of net sales in the prior year-to-date period. The decreases in selling, general and administrative expenses as a rate of sales was due primarily to lower incentive compensation expense compared to the prior year and a reduction in the supply chain expense rates as a result of efficiencies realized from the Company's supply chain transformation initiative. These decreases were partially offset by organizational realignment costs related to the previously announced go-to-market plan.

Acquisition and Integration, net – Third quarter and prior year quarter results included net charges of $2.1 million and net gains of $0.6 million, respectively. Acquisition and integration expenses for the year-to-date periods ended October 7, 2023 and October 8, 2022 included charges of $2.3 million and $0.1 million, respectively. Current year activity primarily consists of expenses associated with the Company's acquisition efforts within the Retail segment. The prior year quarter activity primarily consisted of a gain from the reversal of a litigation accrual within the Retail segment. Prior year-to-date expense is primarily related to an acquisition within the Retail segment, partially offset by the reversal of the litigation accrual in the prior year quarter.

Restructuring and Asset Impairment, net – Third quarter and prior year quarter results included net gains of $0.5 million and $0.9 million, respectively. The year-to-date period and prior year-to-date period included charges of $1.4 million and $1.7 million, respectively. The current quarter gain primarily relates to a $0.3 million gain for additional insurance proceeds related to a distribution location that sustained significant storm damage within the Wholesale segment, in addition to revised estimates for turnover and other lease ancillary costs associated with previously closed locations. The year-to-date net charges primarily relate to two store closures within the Retail segment and impairment losses related to a distribution location that sustained significant storm damage within the Wholesale segment, partially offset by the sale of a store within the Retail segment. The prior year quarter income was primarily due to gains on the sales of real property of previously closed locations within both segments, partially offset by Retail store closing charges and asset impairment charges related to the restructuring of the Retail segment's e-commerce delivery model. The prior year-to-date expense primarily consists of asset impairment charges related to the restructuring of the Retail segment's e-commerce delivery model and Retail store closing charges, partially offset by a gain on sales of assets related to the sale of real property of previously closed locations in both segments.

21


Operating Earnings The following table presents operating earnings by segment and variances in operating earnings.

12 Weeks Ended

40 Weeks Ended

(In thousands)

October 7, 2023

October 8, 2022

Variance

October 7, 2023

October 8, 2022

Variance

Wholesale

$

18,153

$

14,015

$

4,138

$

66,020

$

54,834

$

11,186

Retail

4,918

5,285

(367

)

17,150

4,944

12,206

Total operating earnings

$

23,071

$

19,300

$

3,771

$

83,170

$

59,778

$

23,392

Operating earnings increased $3.8 million, or 19.5% to $23.1 million in the third quarter from $19.3 million in the prior year quarter. Operating earnings for the year-to-date period increased $23.4 million, or 39.1%, to $83.2 million from $59.8 million in the prior year-to-date period. The increases in operating earnings was due to the changes in net sales, gross profit and operating expenses discussed above.

Wholesale operating earnings increased $4.1 million, or 29.5%, to $18.2 million in the third quarter from $14.0 million in the prior year quarter. Operating earnings for the year-to-date period increased $11.2 million, or 20.4%, to $66.0 million from $54.8 million in the prior year-to-date period. The increases in operating earnings were due to benefits realized from the merchandising transformation initiative, lower incentive compensation as well as efficiencies realized from the Company's supply chain transformation initiative. The increases in operating earnings were partially offset by the anticipated lower inflation-related price change benefits compared to elevated levels in the prior year.

Retail operating earnings decreased $0.4 million, or 6.9%, to $4.9 million in the third quarter from $5.3 million in the prior year quarter. Operating earnings for the year-to-date period increased $12.2 million, to $17.2 million from $4.9 million in the prior year-to-date period. The decrease in operating earnings in the current quarter was due to higher acquisition and integration expenses, a decline in unit volume, and lower pharmacy margin rates. This was partially offset by lower incentive compensation and reduced asset impairment and restructuring charges. The increase in operating earnings in the year-to-date period was due to higher gross margin driven by inflation, lower incentive compensation and reduced asset impairment and restructuring charges, partially offset by a decline in unit volume.

Interest Expense – Interest expense increased $3.2 million, or 53.4%, to $9.3 million in the third quarter from $6.1 million in the prior year quarter. Interest expense for the year-to-date period increased $15.5 million, or 104.7%, to $30.2 million from $14.8 million in the prior year-to-date period. Higher interest rates on the Company's credit facility were driven by federal monetary policy tightening and accounted for $2.5 million and $12.6 million of the increase in interest expense in the quarterly and year-to-date periods, respectively.

Income Taxes – The effective income tax rates were 23.7% and 32.5% for the third quarter and prior year quarter, respectively. For the year-to-date period and prior year-to-date period, the effective tax rates were 24.4% and 25.4%, respectively. The difference from the federal statutory rate in the current year and prior year quarters were primarily due to state taxes and non-deductible expenses, partially offset by benefits associated with federal tax credits. The difference from the federal statutory rate in the current year was primarily due to state taxes and non-deductible expenses, partially offset by benefits associated with federal tax credits, discrete tax benefits due to a change in contingencies and discrete tax benefits related to stock compensation. The difference in the federal statutory rate in the prior year was primarily due to state taxes, limitations on the deductibility of executive compensation and non-deductible expenses, partially offset by benefits associated with federal tax credits and discrete tax benefits related to stock compensation.

Non-GAAP Financial Measures

In addition to reporting financial results in accordance with GAAP, the Company also provides information regarding adjusted operating earnings, adjusted earnings from continuing operations, as well as per diluted share (“adjusted EPS”), net long-term debt, total capital, and adjusted earnings before interest, taxes, depreciation and amortization (“adjusted EBITDA”). These are non-GAAP financial measures, as defined below, and are used by management to allocate resources, assess performance against its peers and evaluate overall performance. The Company believes these measures provide useful information for both management and its investors. The Company believes these non-GAAP measures are useful to investors because they provide additional understanding of the trends and special circumstances that affect its business. These measures provide useful supplemental information that helps investors to establish a basis for expected performance and the ability to evaluate actual results against that expectation. The measures, when considered in connection with GAAP results, can be used to assess the overall performance of the Company as well as assess the Company’s performance against its peers. These measures are also used as a basis for certain compensation programs sponsored by the Company. In addition, securities analysts, fund managers and other shareholders and stakeholders that communicate with the Company request its financial results in these adjusted formats.

22


Current year adjusted operating earnings, adjusted earnings from continuing operations, and adjusted EBITDA exclude, among other items, LIFO expense, organizational realignment, severance associated with cost reduction initiatives, a non-routine settlement related to a legal matter resulting from a previously closed operation that was resolved during the year and operating and non-operating costs associated with the postretirement plan amendment and settlement. Current year organizational realignment includes consulting and severance costs associated with the Company's change in its go-to-market strategy as part of its long-term plan, which relates to the reorganization of certain functions. Costs related to the postretirement plan amendment and settlement include non-operating expenses associated with amortization of the prior service credit related to the amendment of the retiree medical plan, which are excluded from adjusted earnings from continuing operations. Postretirement plan amendment and settlement costs also include operating expenses related to payroll taxes which are adjusted out of all non-GAAP financial measures. Prior year adjusted operating earnings, adjusted earnings from continuing operations, and adjusted EBITDA exclude, among other things, LIFO expense, costs related to shareholder activism, organizational realignment, operating and non-operating costs associated with the postretirement plan amendment and settlement, and severance associated with cost reduction initiatives. Costs related to shareholder activism include consulting, and other expenses incurred in relation to shareholder activism activities. Organizational realignment includes benefits for associates terminated as part of leadership transition plans, which do not meet the definition of reduction-in-force.

Each of these items are considered “non-operational” or “non-core” in nature.

Adjusted Operating Earnings

Adjusted operating earnings is a non-GAAP operating financial measure that the Company defines as operating earnings plus or minus adjustments for items that do not reflect the ongoing operating activities of the Company and costs associated with the closing of operational locations.

The Company believes that adjusted operating earnings provide a meaningful representation of its operating performance for the Company as a whole and for its operating segments. The Company considers adjusted operating earnings as an additional way to measure operating performance on an ongoing basis. Adjusted operating earnings is meant to reflect the ongoing operating performance of all of its distribution and retail operations; consequently, it excludes the impact of items that could be considered “non-operating” or “non-core” in nature and also excludes the contributions of activities classified as discontinued operations. Because adjusted operating earnings and adjusted operating earnings by segment are performance measures that management uses to allocate resources, assess performance against its peers and evaluate overall performance, the Company believes it provides useful information for both management and its investors. In addition, securities analysts, fund managers and other shareholders and stakeholders that communicate with the Company request its operating financial results in an adjusted operating earnings format.

Adjusted operating earnings is not a measure of performance under GAAP and should not be considered as a substitute for operating earnings, and other income statement data. The Company’s definition of adjusted operating earnings may not be identical to similarly titled measures reported by other companies.

23


Following is a reconciliation of operating earnings to adjusted operating earnings for the 12 and 40 weeks ended October 7, 2023 and October 8, 2022.

12 Weeks Ended

40 Weeks Ended

(In thousands)

October 7, 2023

October 8, 2022

October 7, 2023

October 8, 2022

Operating earnings

$

23,071

$

19,300

$

83,170

$

59,778

Adjustments:

LIFO expense

6,606

14,884

22,445

42,916

Acquisition and integration, net

2,130

(577

)

2,259

98

Restructuring and asset impairment, net

(458

)

(886

)

1,371

1,738

Organizational realignment, net

2,681

588

4,710

1,859

Severance associated with cost reduction initiatives

39

54

311

795

Legal settlement

900

Postretirement plan amendment and settlement

94

133

Costs related to shareholder activism

7,335

Adjusted operating earnings

$

34,069

$

33,363

$

115,260

$

114,652

Wholesale:

Operating earnings

$

18,153

$

14,015

$

66,020

$

54,834

Adjustments:

LIFO expense

4,411

12,959

16,734

35,138

Acquisition and integration, net

65

189

Restructuring and asset impairment, net

(293

)

(2,088

)

688

(2,216

)

Organizational realignment, net

1,673

367

2,939

1,160

Severance associated with cost reduction initiatives

39

43

296

662

Legal settlement

900

Postretirement plan amendment and settlement

59

83

Costs related to shareholder activism

4,577

Adjusted operating earnings

$

24,048

$

25,296

$

87,825

$

94,238

Retail:

Operating earnings

$

4,918

$

5,285

$

17,150

$

4,944

Adjustments:

LIFO expense

2,195

1,925

5,711

7,778

Acquisition and integration, net

2,065

(577

)

2,070

98

Restructuring and asset impairment, net

(165

)

1,202

683

3,954

Organizational realignment, net

1,008

221

1,771

699

Severance associated with cost reduction initiatives

11

15

133

Postretirement plan amendment and settlement

35

50

Costs related to shareholder activism

2,758

Adjusted operating earnings

$

10,021

$

8,067

$

27,435

$

20,414

Adjusted Earnings from Continuing Operations

Adjusted earnings from continuing operations, as well as per diluted share ("adjusted EPS"), is a non-GAAP operating financial measure that the Company defines as net earnings plus or minus adjustments for items that do not reflect the ongoing operating activities of the Company and costs associated with the closing of operational locations.

The Company believes that adjusted earnings from continuing operations provide a meaningful representation of its operating performance for the Company. The Company considers adjusted earnings from continuing operations as an additional way to measure operating performance on an ongoing basis. Adjusted earnings from continuing operations is meant to reflect the ongoing operating performance of all of its distribution and retail operations; consequently, it excludes the impact of items that could be considered “non-operating” or “non-core” in nature, and excludes the contributions of activities classified as discontinued operations. Because adjusted earnings from continuing operations is a performance measure that management uses to allocate resources, assess performance against its peers and evaluate overall performance, the Company believes it provides useful information for both management and its investors. In addition, securities analysts, fund managers and other shareholders and stakeholders that communicate with the Company request its operating financial results in adjusted earnings from continuing operations format.

Adjusted earnings from continuing operations is not a measure of performance under GAAP and should not be considered as a substitute for net earnings, cash flows from operating activities and other income or cash flow statement data. The Company’s definition of adjusted earnings from continuing operations may not be identical to similarly titled measures reported by other companies.

24


Following is a reconciliation of net earnings to adjusted earnings from continuing operations for the 12 weeks ended October 7, 2023 and October 8, 2022.

12 Weeks Ended

October 7, 2023

October 8, 2022

per diluted

per diluted

(In thousands, except per share amounts)

Earnings

share

Earnings

share

Net earnings

$

11,127

$

0.32

$

9,464

$

0.26

Adjustments:

LIFO expense

6,606

14,884

Acquisition and integration, net

2,130

(577

)

Restructuring and asset impairment, net

(458

)

(886

)

Organizational realignment, net

2,681

588

Severance associated with cost reduction initiatives

39

54

Postretirement plan amendment and settlement

(762

)

(763

)

Total adjustments

10,236

13,300

Income tax effect on adjustments (a)

(2,600

)

(2,725

)

Total adjustments, net of taxes

7,636

0.22

10,575

0.29

Adjusted earnings from continuing operations

$

18,763

$

0.54

$

20,039

$

0.55

40 Weeks Ended

October 7, 2023

October 8, 2022

per diluted

per diluted

(In thousands, except per share amounts)

Earnings

share

Earnings

share

Net earnings

$

41,932

$

1.20

$

33,868

$

0.93

Adjustments:

LIFO expense

22,445

42,916

Acquisition and integration, net

2,259

98

Restructuring and asset impairment, net

1,371

1,738

Organizational realignment, net

4,710

1,859

Severance associated with cost reduction initiatives

311

795

Pension refund from annuity provider

(200

)

Postretirement plan amendment and settlement

(2,411

)

(18

)

Legal settlement

900

Costs related to shareholder activism

7,335

Total adjustments

29,585

54,523

Income tax effect on adjustments (a)

(7,525

)

(13,870

)

Total adjustments, net of taxes

22,060

0.63

40,653

1.12

Adjusted earnings from continuing operations

$

63,992

$

1.83

$

74,521

$

2.05

(a)
The income tax effect on adjustments is computed by applying the effective tax rate, before discrete tax items, to the total adjustments for the period.

25


Adjusted EBITDA

Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”) is a non-GAAP operating financial measure that the Company defines as net earnings plus interest, discontinued operations, depreciation and amortization, and other non-cash items, including share-based payments (equity awards measured in accordance with ASC 718, Stock Compensation , which include both stock-based compensation to employees and stock warrants issued to non-employees) and the LIFO provision, as well as adjustments for items that do not reflect the ongoing operating activities of the Company.

The Company believes that adjusted EBITDA provides a meaningful representation of its operating performance for the Company and for its operating segments. The Company considers adjusted EBITDA as an additional way to measure operating performance on an ongoing basis. Adjusted EBITDA is meant to reflect the ongoing operating performance of all of its distribution and retail operations; consequently, it excludes the impact of items that could be considered “non-operating” or “non-core” in nature, and also excludes the contributions of activities classified as discontinued operations. Because adjusted EBITDA and adjusted EBITDA by segment are performance measures that management uses to allocate resources, assess performance against its peers and evaluate overall performance, the Company believes it provides useful information for both management and its investors. In addition, securities analysts, fund managers and other shareholders and stakeholders that communicate with the Company request its operating financial results in adjusted EBITDA format.

Adjusted EBITDA and adjusted EBITDA by segment are not measures of performance under GAAP and should not be considered as a substitute for net earnings, cash flows from operating activities and other income or cash flow statement data. The Company’s definitions of adjusted EBITDA and adjusted EBITDA by segment may not be identical to similarly titled measures reported by other companies.

26


Following is a reconciliation of net earnings to adjusted EBITDA for the 12 and 40 weeks ended October 7, 2023 and October 8, 2022.

12 Weeks Ended

40 Weeks Ended

(In thousands)

October 7, 2023

October 8, 2022

October 7, 2023

October 8, 2022

Net earnings

$

11,127

$

9,464

$

41,932

$

33,868

Income tax expense

3,450

4,553

13,530

11,530

Other expenses, net

8,494

5,283

27,708

14,380

Operating earnings

23,071

19,300

83,170

59,778

Adjustments:

LIFO expense

6,606

14,884

22,445

42,916

Depreciation and amortization

23,042

21,833

75,245

72,274

Acquisition and integration, net

2,130

(577

)

2,259

98

Restructuring and asset impairment, net

(458

)

(886

)

1,371

1,738

Cloud computing amortization

1,259

925

3,685

2,694

Organizational realignment, net

2,681

588

4,710

1,859

Severance associated with cost reduction initiatives

39

54

311

795

Stock-based compensation

2,461

1,370

10,073

7,208

Stock warrant

319

505

1,279

1,659

Non-cash rent

(531

)

(764

)

(2,094

)

(2,691

)

Loss (gain) on disposal of assets

258

63

304

(68

)

Legal settlement

900

Postretirement plan amendment and settlement

94

133

Costs related to shareholder activism

7,335

Adjusted EBITDA

$

60,877

$

57,295

$

203,752

$

195,728

Wholesale:

Operating earnings

$

18,153

$

14,015

$

66,020

$

54,834

Adjustments:

LIFO expense

4,411

12,959

16,734

35,138

Depreciation and amortization

12,151

11,090

39,165

36,602

Acquisition and integration, net

65

189

Restructuring and asset impairment, net

(293

)

(2,088

)

688

(2,216

)

Cloud computing amortization

834

645

2,499

1,873

Organizational realignment, net

1,673

367

2,939

1,160

Severance associated with cost reduction initiatives

39

43

296

662

Stock-based compensation

1,621

894

6,615

4,743

Stock warrant

319

505

1,279

1,659

Non-cash rent

(92

)

(138

)

(288

)

Loss (gain) on disposal of assets

24

(26

)

(11

)

(184

)

Legal settlement

900

Postretirement plan amendment and settlement

59

83

Costs related to shareholder activism

4,577

Adjusted EBITDA

$

38,997

$

38,312

$

137,234

$

138,643

Retail:

Operating earnings

$

4,918

$

5,285

$

17,150

$

4,944

Adjustments:

LIFO expense

2,195

1,925

5,711

7,778

Depreciation and amortization

10,891

10,743

36,080

35,672

Acquisition and integration, net

2,065

(577

)

2,070

98

Restructuring and asset impairment, net

(165

)

1,202

683

3,954

Cloud computing amortization

425

280

1,186

821

Organizational realignment, net

1,008

221

1,771

699

Severance associated with cost reduction initiatives

11

15

133

Stock-based compensation

840

476

3,458

2,465

Non-cash rent

(531

)

(672

)

(1,956

)

(2,403

)

Loss on disposal of assets

234

89

315

116

Postretirement plan amendment and settlement

35

50

Costs related to shareholder activism

2,758

Adjusted EBITDA

$

21,880

$

18,983

$

66,518

$

57,085

27


Liquidity and Capital Resources

Cash Flow Information

The following table summarizes the Company’s consolidated statements of cash flows:

40 Weeks Ended

(In thousands)

October 7, 2023

October 8, 2022

Cash flow activities

Net cash provided by operating activities

$

95,680

$

7,454

Net cash used in investing activities

(82,003

)

(45,956

)

Net cash (used in) provided by financing activities

(25,209

)

46,800

Net (decrease) increase in cash and cash equivalents

(11,532

)

8,298

Cash and cash equivalents at beginning of the period

29,086

10,666

Cash and cash equivalents at end of the period

$

17,554

$

18,964

Net cash provided by operating activities. Net cash provided by operating activities increased $88.2 million in the current year-to-date period compared to the prior year-to-date period, due primarily to improvements in working capital.

Net cash used in investing activities. Net cash used in investing activities increased $36.0 million in the current year compared to the prior year primarily due to net proceeds received from the sale of assets in the prior year and an increase in capital expenditures in the current year in line with the Company's long-term plan, partially offset by an acquisition within the Retail segment in the prior year.

Capital expenditures were $86.2 million in the current year and cloud computing application development spend, which is included in operating activities, was $4.1 million, compared to capital expenditures of $66.3 million and cloud computing application development spend of $3.2 million in the prior year. The Wholesale and Retail segments utilized 63.2% and 36.8% of capital expenditures, respectively, in the current year.

Net cash (used in) provided by financing activities. Net cash (used in) provided by financing activities increased $72.0 million in the current year compared to the prior year, primarily due to an increased rate of borrowing in the prior year on the senior credit facility.

Debt Management

Total debt, including finance lease liabilities, was $544.2 million and $503.6 million as of October 7, 2023 and December 31, 2022, respectively. The increase in total debt was due to additional net borrowings on the senior credit facility to fund working capital changes, purchases of property, plant and equipment and share repurchases.

Liquidity

The Company’s principal sources of liquidity are cash flows generated from operations and its senior secured credit facility, which includes Tranche A revolving loans, with a borrowing capacity of $1.09 billion, and Tranche A-1 revolving loans, with a borrowing capacity of $40 million. As of October 7, 2023, the senior secured credit facility had outstanding borrowings of $472.6 million. During the first quarter, the Company increased the borrowing capacity of Tranche A revolving loans by $115.0 million to $1.09 billion from $975.0 million through the addition of two new lenders. This expansion of borrowing capacity aligns with the Company's recent growth and provides flexibility to support the Company's strategic long-term plans, including both organic and inorganic investments.

Additional available borrowings under the Company’s credit facility are based on stipulated advance rates on eligible assets, as defined in the Credit Agreement. The Credit Agreement requires that the Company maintain excess availability of 10% of the borrowing base, as such term is defined in the Credit Agreement. The Company had excess availability after the 10% covenant of $518.2 million at October 7, 2023. Payment of dividends and repurchases of outstanding shares are permitted, provided that certain levels of excess availability are maintained. The credit facility provides for the issuance of letters of credit, of which $17.7 million were outstanding as of October 7, 2023. The credit facility matures November 17, 2027 and is secured by substantially all of the Company’s assets.

The Company believes that cash generated from operating activities and available borrowings under the credit facility will be sufficient to meet anticipated requirements for working capital, capital expenditures, dividend payments, and debt service obligations for the foreseeable future. However, there can be no assurance that the business will continue to generate cash flow at or above current levels or that the Company will maintain its ability to borrow under the Credit Agreement.

The Company’s current ratio (current assets to current liabilities) was 1.59-to-1 at October 7, 2023 compared to 1.51-to-1 at December 31, 2022, and its investment in working capital was $405.7 million at October 7, 2023 compared to $361.4 million at December 31, 2022. The net long-term debt to total capital ratio was 0.40-to-1 at October 7, 2023 compared to 0.38-to-1 at December 31, 2022.

28


Net long-term debt is a non-GAAP financial measure that is defined as long-term debt and finance lease liabilities, plus current portion of long-term debt and finance lease liabilities, less cash and cash equivalents. The ratio of net long-term debt to total capital is a non-GAAP financial measure that is calculated by dividing net long-term debt, as defined previously, by total capital (net long-term debt plus total shareholders’ equity). The Company believes both management and its investors find the information useful because it reflects the amount of long-term debt obligations that are not covered by available cash and temporary investments. Total net long-term debt is not a substitute for GAAP financial measures and may differ from similarly titled measures of other companies.

Following is a reconciliation of “Long-term debt and finance lease liabilities” to Net long-term debt as of October 7, 2023 and December 31, 2022.

(In thousands)

October 7, 2023

December 31, 2022

Current portion of long-term debt and finance lease liabilities

$

8,410

$

6,789

Long-term debt and finance lease liabilities

535,804

496,792

Total debt

544,214

503,581

Cash and cash equivalents

(17,554

)

(29,086

)

Net long-term debt

$

526,660

$

474,495

Following is a reconciliation of "Net long-term debt" and "Total shareholders' equity" to Total capital as of October 7, 2023 and December 31, 2022.

(In thousands)

October 7, 2023

December 31, 2022

Net long-term debt

$

526,660

$

474,495

Total shareholders' equity

777,267

766,068

Total capital

$

1,303,927

$

1,240,563

For information on material cash requirements, see the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. At October 7, 2023, there have been no significant changes to the Company’s material cash requirements outside the ordinary course of business.

Cash Dividends

During the quarter ended October 7, 2023, the Company declared $7.5 million in dividends. A 2.4% increase in the quarterly dividend rate from $0.21 per share to $0.215 per share was approved by the Board of Directors and announced on March 1, 2023. Although the Company expects to continue to pay a quarterly cash dividend, adoption of a dividend policy does not commit the Board of Directors to declare future dividends. Each future dividend will be considered and declared by the Board of Directors at its discretion. Whether the Board of Directors continues to declare dividends depends on a number of factors, including the Company’s future financial condition, anticipated profitability and cash flows and compliance with the terms of its credit facilities.

Under the senior revolving credit facility, the Company is generally permitted to pay dividends in any fiscal year up to an amount such that all cash dividends, together with any cash distributions and share repurchases, do not exceed $35.0 million. Additionally, the Company is generally permitted to pay cash dividends and repurchase shares in excess of $35.0 million in any fiscal year so long as its Excess Availability, as defined in the senior revolving credit facility, is in excess of 15% of the Total Borrowing Base, as defined in the senior revolving credit facility, before and after giving effect to the repurchases and dividends.

Off-Balance Sheet Arrangements

The Company has also made certain commercial commitments that extend beyond October 7, 2023. These commitments consist primarily of purchase commitments, standby letters of credit of $17.7 million as of October 7, 2023, and interest on long-term debt and finance lease liabilities.

Critical Accounting Policies

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that may not be readily apparent from other sources. Based on the Company’s ongoing review, the Company makes adjustments it considers appropriate under the facts and circumstances. This discussion and analysis of the Company’s financial condition and results of operations is based upon the Company’s consolidated financial statements. The Company believes these accounting policies and others set forth in Item 7 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 should be reviewed as they are integral to understanding the Company’s financial condition and results of operations. The Company has discussed the development, selection and disclosure of these accounting policies with the Audit Committee of the Board of Directors. The accompanying financial statements are prepared using the same critical accounting policies discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

29


Recently Issued Accounting Standards

Refer to Note 2 in the notes to the condensed consolidated financial statements for further information.

ITEM 3. Quantitative and Qualitative Disclosure about Market Risk

There have been no material changes in market risk of SpartanNash from the information provided in Part II, Item 7A, “Quantitative and Qualitative Disclosure About Market Risk,” of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, with the exception of the interest rate swap entered into during the first quarter of 2023 described below.

As of October 7, 2023, the Company maintained an interest rate swap agreement with a maturity date of November 17, 2027 with an aggregate notional amount totaling $150 million. An interest rate swap is an agreement that effectively converts a portion of the variable interest payable on $150 million of the Company's outstanding debt to a fixed rate. The fixed interest rate for the interest rate swap is 3.646%. The variable rate leg of the interest rate swap is the one-month Secured Overnight Financing Rate (SOFR). As of October 7, 2023, the fair value of the interest rate swap was recorded in "Prepaid expenses and other current assets" and "Other assets, net" for $2.5 million and $2.3 million, respectively, and "Accumulated other comprehensive income" for $3.7 million, net of tax.

ITEM 4. Controls and Procedure s

An evaluation of the effectiveness of the design and operation of SpartanNash Company’s disclosure controls and procedures (as currently defined in Rule 13a-15(e) under the Exchange Act) was performed as of October 7, 2023 (the “Evaluation Date”). This evaluation was performed under the supervision and with the participation of SpartanNash Company’s management, including its Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”) and Corporate Controller. As of the Evaluation Date, SpartanNash Company’s management, including the CEO, CFO and Corporate Controller, concluded that SpartanNash’s disclosure controls and procedures were effective as of the Evaluation Date to ensure that material information required to be disclosed in the reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports that the Company files or submits under the Securities and Exchange Act of 1934 is accumulated and communicated to management, including its principal executive and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. During the third quarter of 2023 there were no changes that materially affected, or were reasonably likely to materially affect, SpartanNash’s internal control over financial reporting.

PART II

OTHER INFORMATION

The information required by this Part II, Item 1 is incorporated by reference to the information set forth under the caption “Commitments and Contingencies” in Note 8 in the notes to condensed consolidated financial statements included in this report.

ITEM 1A. Risk Factors

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K (2022 10-K) for the year ended December 31, 2022 filed with Securities and Exchange Commission. You should carefully consider the risks included in our 2022 10-K, together with all the other information in this Quarterly Report on Form 10-Q, including the forward-looking statements which appear at the beginning of this report.

30


ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

On February 24, 2022, the Board of Directors authorized the repurchase of common shares in connection with a $50 million share repurchase program, which expires on February 22, 2027. There were not any repurchases of common stock made under this program during the third quarter of 2023. At October 7, 2023, $25.5 million remains available under the program. Repurchases of common stock may include: (1) shares of SpartanNash common stock delivered in satisfaction of the exercise price and/or tax withholding obligations by holders of employee stock options who exercised options, and (2) shares submitted for cancellation to satisfy tax withholding obligations that occur upon the vesting of the restricted shares. The value of the shares delivered or withheld is determined by the applicable stock compensation plan. The Company plans to return value to shareholders through share repurchases under this program as well as continuing regular dividends.

Fiscal Period

Total Number of Shares Purchased

Average Price Paid per Share

Total Number of Shares Purchased as Part of Publicly Announced Programs

Maximum Dollar Value of Shares Yet to be Purchased Under the Plans or Programs
(in thousands)

July 16 - August 12, 2023

Employee Transactions

89

$

23.47

N/A

N/A

Repurchase Program

$

$

25,467

August 13 - September 9, 2023

Employee Transactions

418

$

22.14

N/A

N/A

Repurchase Program

$

$

25,467

September 10 - October 7, 2023

Employee Transactions

94

$

21.04

N/A

N/A

Repurchase Program

$

$

25,467

Total for quarter ended October 7, 2023

Employee Transactions

601

$

22.16

N/A

N/A

Repurchase Program

$

$

25,467

31


ITEM 6. Exhibits

The following documents are filed as exhibits to this Quarterly Report on Form 10-Q:

Exhibit
Number

Document

3.1

Restated Articles of Incorporation of SpartanNash Company, as amended. Previously filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended July 15, 2017. Incorporated herein by reference.

3.2

Bylaws of SpartanNash Company, as amended. Previously filed as an exhibit to the Company's Current Report of Form 8-K filed on August 25, 2023.

31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

104

The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended October 7, 2023, has been formatted in Inline XBRL.

32


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SPARTANNASH COMPANY

(Registrant)

Date: November 9, 2023

By

/s/ Jason Monaco

Jason Monaco

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

Date: November 9, 2023

By

/s/ R. Todd Riksen

R. Todd Riksen

Vice President and Corporate Controller

(Principal Accounting Officer)

33


TABLE OF CONTENTS
Part IItem 1. Financial StatementsNote 1 Summary Of Significant Accounting Policies and Basis Of PresentationNote 2 Adoption Of New Accounting Standards and Recently Issued Accounting StandardsNote 3 RevenueNote 4 Goodwill and Other Intangible AssetsNote 5 Restructuring and Asset ImpairmentNote 6 Fair Value MeasurementsNote 7 DerivativesNote 8 Commitments and ContingenciesNote 9 Associate Retirement PlansNote 10 Income TaxesNote 11 Stock-based CompensationNote 12 Earnings Per ShareNote 13 Supplemental Cash Flow InformationNote 14 Segment InformationItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 2. Management S Discussion and Analysis Of FinaItem 3. Quantitative and Qualitative Disclosure About Market RiskItem 4. Controls and ProceduresItem 4. Controls and ProcedurePart IIItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 6. Exhibits

Exhibits

3.1 Restated Articles of Incorporation of SpartanNash Company, as amended.Previously filed as an exhibit to the Companys Quarterly Report on Form 10-Q for the quarter ended July 15, 2017. Incorporated herein by reference. 3.2 Bylaws of SpartanNash Company, as amended.Previously filed as an exhibit to the Company's Current Report of Form 8-K filed on August 25, 2023. 31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1 Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.